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One of the most commonly associated complications of Diabetes Mellitus is nephropathy, 
with one in five diabetics sustaining renal injury over their lives. Renal denervation has been 
shown to decrease systemic blood pressure and increase renal function, by removing 
sympathetic innervation to the kidneys. Our lab investigated the effects of renal denervation 
on diabetic nephropathy in hypertensive rats and found it decreased a range of injury markers, 
such as TGF-β1. It is possible that part of the renoprotection afforded by renal denervation in 
hypertensive diabetics is due to decreased adrenergic signalling. 
This study aimed to determine the effects of combined noradrenaline and glucose on proximal 
tubule cells and their profibrotic signalling, by measuring the excretion of the prosclerotic 
cytokine, TGF-β1. HK-2 cells were treated with a range of glucose concentrations (Control: 
None, Normoglycaemic: 6.1 mmol/L D-glucose, Hyperglycaemic: 25 mmol/L D-glucose, 
Osmotic Control: 6.1 mmol/L D-glucose + 18.9 mmol/L D-mannitol) in the presence of 
noradrenaline (1 nM) or a control (PBS or 0.1 nM ascorbic acid). After 48 hours the samples 
were harvested and levels of TGF-β1 measured via western blot. However, the cells were 
severely damaged by washing. The primary aim of investigation subsequently became the 
optimisation of plating protocols. Seeding densities, growth time and well size were 
increased, extensions to growth arrest and low serum (2%) growth arrest media used, as well 
as a range of different wash solutions and culture surfaces. By increasing the seeding density 
to 2x10
5
 cells/mL and surface area up to a 100 mm culture dish a monolayer was formed that 
could repeatedly survive the wash phases (P<0.001). 
The initial study recommenced and western blotting was unable to find any trace of TGF-β1 in 
either the cell lysate or conditioned media. These findings suggest that neither alone nor 
together noradrenaline and glucose do not cause an upregulation of the production and 
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1.1 Diabetic nephropathy 
 
Diabetes mellitus (DM) is a group of metabolic diseases that result in high blood glucose, 
diagnosed as greater than 126 mg/dL of plasma glucose after an eight hour fast (American 
Diabetes Association, 2014). Broadly, DM is caused by decreased insulin production or 
dysfunction of the respective receptor. Depending on the origin of the glucose rise DM can be 
further categorised, the three main categories being; Type I, Type II and Gestational Diabetes.  
Type I DM is predominantly due to an autoimmune breakdown of insulin producing beta cells 
in the pancreas (Daneman, 2006). Type II DM is a combination of insulin resistance and 
decreased insulin production, these contributing factors vary between patients (Kahn, 1994). 
Hyperglycaemia can also be due to insulin resistance as seen in Gestational DM, where non-
diabetic women in pregnancy experience high blood glucose as a result of insulin receptor 
dysfunction (King, 1998).   
As of 2011, 347 million people worldwide had been diagnosed with Type I or II DM, with 
many more going undiagnosed (Danaei et al., 2011). Type II remains the most prevalent form 
of DM, accounting for 90% of diagnosed cases. Pathological complications of DM can be 
minimised or prevented with proper glucose control and treatment. However, due to poor 
compliance or limited efficacy complications still result, as seen in 2004: complications 
associated with elevated blood glucose resulted in the deaths of 3.4 million people globally 
(World Health Organization, 2009). By 2030, it is predicted that DM will be the 7
th
 highest 
cause of death worldwide (Alwan, 2011). One of the most commonly associated 
complications of DM is diabetic nephropathy (DN), with 1 in 5 diabetics developing renal 
injury over the course of their lives (Vallon, 2011). This association has resulted in DM being 
the largest cause of end-stage renal disease, accounting for 45% of all cases requiring renal 
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replacement (Hostetter, 1991; Collins et al., 2010). In 2012 New Zealand had 3993 patients 
undergoing renal replacement treatment for end stage renal disease (ESRD), of which 1524 
had undergone a kidney transplant while the rest remained on dialysis (Grace et al., 2013). 
1.1.1 Stages of DN 
 
DN is a progressive disease which can be categorised into 5 stages effectively defining the 
extent of its progression (Mogensen et al., 1983). These stages categorise the functional 
changes caused by morphological maladaptation.  Stage 1 and 2 constitute the early 
pathological states with reported presentations of renal hypertrophy, hyperfiltration (increased 
glomerular filtration rate; GFR) and increased renal plasma flow (RPF) (Christiansen et al., 
1981). Stage 2 has histological evidence of glomerular lesions, unlike Stage 1 where renal 
structures are still intact (Christiansen et al., 1982). The progression of DN can be minimised 
at this point by good glycaemic and hypertensive control, as these factors put extra strain on 
the glomerulus, progressing the disease (Mogensen, 1971). However, because patients still 
appear asymptomatic few are treated at this stage. The main clinical symptom of DN; urinary 
albumin, is not yet present unless RPF is increased; such as in exercise (Christiansen et al., 
1982; Koh et al., 2011). 
Most patients are diagnosed at Stage 3 or Incipient DN, as urinary albumin levels begin to 
creep above normal levels to clinical recognition of microalbuminuria (20-200 μg/min of 
protein in urine; American Diabetic Association, 2002). GFR is mostly preserved at this stage 
but due to the multifactorial nature of DN, patients may experience increased or decreased 
GFR (Mogensen et al., 1983). While detection allows some diabetics to be treated at this 
stage, many go without intervention, resulting in 80% of Type I diabetics and 40% of Type II 
diabetics progressing to Stage 4 (American Diabetic Association, 2002). 
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Stage 4, also known as Overt DN, is the severe increase in proteinuria (>200 μg/min), which 
is accompanied by persistently decreasing GFR (2-20 mL/min/yr; American Diabetic 
Association, 2002). The body counterbalances the decreased sodium (Na
+
) filtration and 
excretion by increasing blood volume in order to dilute the plasma concentration. However, 
the increased volume causes hypertension, which further increases the physical stress on the 
weakened glomerulus (Wolf & Ziyadeh, 1999; Wolf & Ziyadeh, 2007). The gradual decline 
in GFR and increase in blood pressure (BP) results in 50% of patients will progress to ESRD 
within 10 years (Hasslacher et al., 1989; Baek et al., 2012) 
The final stage in DN is ESRD, which is diagnosed by a non-existent GFR (<15 mL/min/1.73 
m
2
) and uraemia, signalling the loss of renal function due to urea and other waste products no 
longer being removed from the blood (American Diabetic Association, 2002). Without 
treatment such as dialysis or renal transplant, loss of renal function will result in death 
(Mogensen et al., 1983). Unfortunately due to a deficit in donated organs many people die 
waiting for transplants, as was seen in 2012, where 384 patients undergoing treatment died as 
a result of ESRD in New Zealand (Grace et al., 2013). 
1.1.2 Structural and functional changes of DN 
  
The glomerulus is a capsular structure encompassing a network of arterioles bringing blood to 
the kidney. It is responsible for filtering plasma to produce filtrate. Glomerular injury occurs 
early in diabetes causing the glomerular basement membrane (BM) to thicken, forming 
fibrotic lesions (Osterby, 1972; Osterby, 1974; Osterby et al, 1990; Drummond & Mauer, 
2002). These lesions are the result of increased collagen Type IV deposition and decreased 
extracellular matrix (ECM) degradation caused by the influx of glucose into cells, modulating 
metabolic pathways (Mason and Wahab, 2003). Glomerulosclerotic lesions progressively 
occur in individual glomeruli throughout the kidney, producing a thickening of the BM 
(Osterby, 1972; Osterby, 1974; Drummond & Mauer, 2002).  
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Mesangial cells are the next to be affected; mesangial cells are specialised smooth muscle 
cells localised around the blood vessels within the kidney, controlling the amount of blood 
flow to the kidney and glomerulus (Fioretto et al., 1994). In nodular sclerosis, mesangial 
expansion increases the mesangial matrix volume resulting in the formation of Kimmelstiel-
Wilson nodules (Falk et al., 1983; Kim et al., 1991; Mason & Wahab, 2003; Fioretto & 
Mauer, 2007). These fibrotic nodules progressively increase in size to compress the 
glomerular capillaries, producing a decrease in GFR during the early stages of DN (White & 
Bilous, 2002; Caramori et al. 2002). 
Podocytes are cells that wrap around the capillaries of the glomerulus forming the Bowman's 
capsule. The podocyte foot processes begin to widen to accommodate the expanding 
glomerular BM, facilitating their detachment and apoptosis causing disruption to the 
Bowman’s capsule (Fioretto & Mauer, 2007; Jefferson et al., 2008). The capsule acts as a 
barrier to larger proteins in the blood preventing their entry into the filtrate. A range of studies 
looking at the breakdown of the Bowman's capsule as a result of changes in podocyte 
morphology have found that this deterioration consistently leads to albuminuria (Ellis et al., 
1987; Bjorn et al., 1995; Laurens et al., 1995; Pavenstadt, 1998; Torbjornsdotter et al., 2005). 
The resulting excreted protein load can consequently provide inducible stress responses to 
include sclerotic and inflammatory pathways on downstream segments of the nephron 
(Hirschberg & Wang, 2005). 
1.2 Hypertension and diabetes 
 
Hypertension is present in around 70% of all diabetics and accelerates renal failure compared 
to normotensive patients (Klein et al., 1996; Stojceva-Taneva et al., 2007). These two 
conditions affect a large and ever growing at-risk population, forming an essential target of 
research. Examination of connected mechanisms may offer novel therapeutic approaches to 
combat the rise of accelerated ESRD disease and renal replacement therapies.  
5 
 
Hypertension is both a causative and resulting complication of diabetes and DN. Both Type I 
and II diabetics have a genetic predisposition to hypertension compared to the general 
population (Barzilay et al., 1992; Qi et al., 2012). Type II diabetes also have a causal relation 
to hypertension through obesity and lifestyle (Mokdad et al., 2003). Hypertension also 
commonly develops during the progression of DN, due to the increased Na
+
 reabsorption and 
resulting blood volume expansion as well as the dysregulation of sympathetic nervous system, 
which leads to peripheral vasoconstriction (Wolf & Ziyadeh, 1999; Wolf & Ziyadeh, 2007). 
Although, hypertension may be a result of many different factors, the final common pathways 
converge to result in increased sympathetic stimulation (Esler, 2000; Esler & Kaye, 2000; 
Masuo, 2002; de Silva et al., 2009; Hall et al., 2010). 
1.2.1 Kidney innervation 
 
Kidneys are highly innervated with both sensory afferent and sympathetic efferent nerves 
(refer to Figure 1.1). The afferent nerves transmit sensory information from glomerular 
mechano- and chemoreceptors, which detect pressure and concentration respectively, to the 
brainstem and hypothalamus (Recordati et al., 1981; Recordati et al., 1982; Ciriello & 
Caverson, 1987). The signal is then processed, and the sympathetic nervous system is either 
inhibited or excited in order to maintain plasma homeostasis. Sympathetic nerves stimulate 
the release of noradrenaline (NA) into the blood from the adrenal medulla, as well as directly 
on to nerve terminals within the kidney. All the regions of the kidney especially the nephrons 
are densely innervated by sympathetic neurons in order to modulate reabsorption of filtrate 




Figure 1.1 A schematic of the renal sympathetic nervous system. Displaying both efferent and 
afferent neuronal pathways. NTS = solitary tract nucleus; PVN = paraventricular nucleus; RVLM = 
rostral ventrolateral medulla. Modified from Bertog et al. (2012). 
 
1.2.1.1 Afferent nerves 
 
In healthy kidneys, afferent nerves primarily act to inhibit sympathetic nerve activation 
through the renorenal reflex (Kopp et al., 1985; Kopp et al., 2007). However afferent nerves 
are also able to induce sympathetic nerve activation through excitatory pathways, in response 
to chemoreceptor stimulation (Recordati et al., 1982; Stella & Zanchetti, 1991). Publications 
using diseased kidney models, report an increase in excitatory afferent signalling which is 
linked to the release of adenosine by proximal tubule cells (PTCs) in the stressed kidney 
(Katholi et al., 1984). Adenosine has been shown to stimulate the afferent nerves via 
chemoreceptors, resulting in turn in elevated sympathetic nerve activity to increase systemic 
hypertension (Katholi et al., 1985).  
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1.2.1.2 Efferent sympathetic nerves 
 
There is significant evidence that sympathetic hyperactivity accelerates the progression of DN 
(Joles & Koomans, 2004). As noted earlier, sympathetic stimulation is the final common 
pathway to hypertension. The increased blood pressure adds haemodynamic stress to the 
glomerulus and nephron, directly causing mechanical breakdown as well as profibrotic 
cytokines and growth factor production, accelerating ESRD (Wolf & Ziyadeh, 1999; Wolf & 
Ziyadeh, 2007). More recent studies have focused on haemodynamic-independent pathways 
of sympathetic hyperactivity affecting DN, such as renal denervation Renal denervation has a 
range of positive effects, including decreased albuminuria and reduced glomerular functional 
loss in rats and human patients (Amann et al., 2000; Strojek et al., 2001). Early renal 
denervation prevented hypertrophy and hyperfiltration in rats, however early studies in 
humans indicated an increased risk of developing microalbuminuria (Chiarelli et al., 1995; 
Luippold et al., 2004). This increased risk was not seen in more recent denervation studies 
indicating a decrease in microalbuminruia (Esler et al., 2012; Ott et al., 2014; Persu et al., 
2014). It would appear, then, that decreasing sympathetic activity can be considered as a 
preventative treatment for high risk individuals. Rat studies involving denervation have an 
inherent amount of error due to the regeneration and re-innervation of kidney nerves 
occurring as early as 2-3 weeks after denervation, which can result in increased sensitivity to 
NA after re-innervation (Kline & Mercer, 1980; Mulder et al., 2013). Re-innervation also 
poses an issue in humans recieveing renal denervation, as re-innervation was recognised in 
older histological studies of dogs indicating that renal re-innervation is not species specific 
(Couch et al., 1961; Norvel & Banes, 1979). Recently our lab looked into renal sympathetic 
denervation of (mRen-2)27 diabetic rats and found a significant decrease in type I and IV 
collagen and fibrosis developing, coinciding with reduced transforming growth factor-beta 1 
(TGF-β1) expression throughout the kidney including the proximal tubules (Yao et al., 2014). 
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This decreased accumulation of collagen and TGF-β1 expression as a consequence of repeated 
chronic denervation in the Type I diabetic hypertensive rat indicates a link between elevated 
sympathetic NA levels and interstitial fibrosis in DN. 
1.2.1.3 Renin-angiotensin system 
 
The renin-angiotensin system (RAS) is a hormone system that regulates systemic and 
intrarenal fluid dynamics. Angiotensin II (Ang II) the final and most potent bioactive 
component of the RAS system triggers the release of aldosterone from the adrenal cortex. 
Aldosterone stimulates Na
+
 and fluid reabsorption in the kidney tubule causing an increase in 
blood volume and therefore blood pressure (Barraclough et al., 1967; Malvin & Vander, 
1967; Harris et al., 1996; Shapiro et al., 2010). Ang II is also vasoactive causing vessels to 
constrict further increasing blood pressure and decreasing GFR (Hsu et al., 1980; Navar et al., 
1986; Blantz et al., 1993; Franco et al., 2001). The RAS system is normally activated in 
response to decreased blood volume such as in dehydration or haemorrhage through a range 
of stimulatory mechanisms. The predominant producer of renin, the juxtoglomerular 
apparatus (JGA) within the kidney releases renin when stimulated such as through the beta 1 
adrenergic receptor (β1-AR) (Sealey et al., 1986; Schweda & Kurtz, 2004). However if 
overstimulated the pathway will result in hypertension and because of this is often targeted for 
hypertensive treatments. Ang II is a produced by the two stage metabolism of 
angiotensinogen. Initially angiotensinogen is cleaved to angiotensin I (Ang I) by renin, Ang I 
is then converted to Ang II by angiotensin converting enzymes (ACE) (Brasier & Li, 1996; 
Navar, 1997; Ichihara et al., 2004).  
While the systemic RAS increases the mechanical stress on kidney filtration through raised 
blood pressure, there is also an intrarenal RAS system which upregulates prosclerotic 
signalling throughout the nephron (Carey & Siragy, 2003). Within the kidney, renin is also 
released by the glomerular, and proximal and distal tubule cells (Terada et al., 1993). Like the 
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systemic RAS, sympathetic hyperactivity will increase Ang II with the intrarenal RAS due to 
increased renin release. This is particularly significant in DN as the abundant intrarenal ACE 
and the local production of angiotensinogen by PTCs results in higher levels of intrarenal Ang 
II than in systemic circulation (Hackenthal et al., 1990; Casarini et al., 1997; Kennefick & 
Anderson, 1997; Schnermann et al., 1997; Ingert et al., 2002; Komlosi et al., 2003) Ang II 
interacts with the Ang II Type 1 (AT1) and 2 (AT2) receptors. The AT2 receptors are found in 
the foetal kidney and the myometrium of adults, while the AT1 receptor is found throughout 
the nephron in adults, including both the basolateral and apical membranes of proximal tubule 
cells (Zhuo et al., 1992). Therefore, the majority of haemodynamic and renal profibrotic 
effects are caused by AT1 receptor activity. The effects of Ang II on pro-fibrotic signalling 
will be discussed later under the β-adrenergic receptors (β-AR) (see chapter 1.3.4.3).  
The RAS in experimental DN has produced a range of conflicting results (Wolf & Ziyadeh, 
1997). Clinical results show that plasma renin activity is generally decreased in DN, which is 
speculated to result from decreased activation of prorenin or impairment of renin release 
(Amemiya et al., 1990). This inconsistency in RAS levels is also seen in the intrarenal system 
with whole kidney measurements indicating suppression (Campbell et al., 1999; Vallon et al., 
1995) or no change (Vora et al., 1997), however the Otasuka Long-Evans Tokushima Fatty 
rat and the Zucker obese rat models have reported stimulatory effects to the RAS (Taniguchi 
et al., 2002; Sharma et al., 2006). Whole kidney analysis however, does not take in-to account 
compartmental increases of the RAS. In streptozotocin (STZ)-induced diabetic animals the 
expression of renin and intracellular angiotensinogen increased in the proximal tubule (Kelly 
et al., 2000; Choi et al., 1997; Zimplemann et al., 2000, respectively). Conclusions were 
drawn that these localised intrarenal increases could result in Ang II stimulating 
tubulointerstitial fibrosis, while remaining undetected in whole kidney measurement. 
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1.3 Renal fibrosis 
  
Renal fibrosis is a response to chronic injury such as that sustained in DN, and is essentially 
caused by the dysregulation of wound healing (Liu, 2006). Initial injury caused by diabetes 
and compounded by hypertension activates cellular pathways which produce pro-fibrotic 
cytokines (Eddy, 2000). This process results in increased collagen deposition and decreased 
degradation of ECM, causing the scaring seen in fibrosis. Overtime, fibrosis becomes more 
pronounced eventually destroying the structure of the kidney’s functional units, inhibiting 
renal function.  
1.3.1 Tubulointerstitial fibrosis as a marker of DN 
 
Although the aetiology of DN is multifactorial, the progression of the disease is characterised 
by the accumulation of profibrotic extracellular proteins causing fibrosis, regardless of the 
triggering insult (Eddy and Neilson, 2006). Consequently, both Mauer et al. (1984) and Bohle 
et al. (1991) demonstrated that the progression of renal dysfunction is best characterised by 
tubular interstitial fibrosis. This was contrary to previous opinion, which considered DN to be 
a disease primarily concerning the glomerulus (Gellman et al., 1959; Osterby & Gundersen, 
1975). While changes to the glomerulus have been recognised as an instigating factor in the 
majority of DN cases, changes in the tubular interstitium are far more important to the 
progression and outcome of DN in patients, as the majority of reabsorption occurs in the 
proximal tubules and is therefore critical to plasma homeostasis (Phillips & Steadman, 2002; 
refer to Figure 1.2). At 80% of the total kidney volume, tubular epithelial cells make up the 
vast majority of the kidney structure, therefore any expansion of interstitial matrix will result 
in significant displacement of the fine structure of the kidney’s functional units (Klahr et al., 
2002; Eddy, 2000). Consequently by damaging the kidney parenchyma, matrix expansion will 
cause further loss of renal function. 
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1.3.2 Hyperglycaemia and the proximal tubule 
 
Although kidney fibrosis is a common consequence of all chronic renal injury pathologies, the 
manner of the initial insult is important to the development of a treatment protocol and to the 
prevention of DN. Consequently, the development of hyperglycaemia in poorly controlled 
diabetic patients and the impact of elevated glucose on the proximal tubule epithelia is 
recognised as a major factor in the progression of DN. 
 
Figure 1.2 Nephron structure (A) and proximal tubule cell transport diagram (B). A: Labelled 
regions and percentage uptake of glucose through transporters SGLT2 and SGLT1. B: Effects of 
hyperglycaaemia, angiotensin II (ANG II) and noradrenaline (NA) on transporter expression, red 
arrow indicates upregulation. GLUT2: Glucose transporter 2; GLUT1: Glucose transporter 1; SGLT2: 
Sodium-glucose transporter 2; SGLT1: Sodium-glucose transporter 2; AT1: Angiotensin II receptor 
type 1; HNF-1α/3β: Hepatocyte nuclear factor-1α/3β; KCNE1/Q1: Potassium voltage-gated channel 
subfamily E member1; α1-AR: α1-Adrenergic receptor. Modified from Vallon (2011). 
 
1.3.2.1 Glucose transport 
 
Proximal tubule cells of the nephron tubule are highly affected by hyperglycaemic conditions 
as their glucose transportation is insulin independent (Vallon, 2011). Proximal tubule cells do 





 as such they will continue to reabsorb glucose as long as there is Na
+
 
(Figure 1.2). Renal tubule Na
+
 reabsorption is primarily conducted through the low-affinity 
high-capacity cotransporter sodium glucose transporter 2 (SGLT2) in the “early” proximal 
tubule (Vallon et al., 2011). SGLT2 transfers glucose and Na
+
 in a 1:1 ratio, whereas the 
sodium glucose transporter 1 (SGLT1) isoform functions at a 1:2 ratio (Mahraoui et al., 
1994). The high-affinity low-capacity cotransporter SGLT1 located primarily in the distal 
sections of the proximal tubules functions to retain any residual glucose in a non-
hyperglycaemic individual, but will reabsorb up to its capacity in hyperglycaemic states. 
Glucose is also able to travel through GLUT2 channels, which are primarily located in the 
early proximal tubule to maximise the larger initial concentration gradient (Mahraoui et al., 
1994). To exacerbate the enhanced glucose uptake, increased intracellular glucose 
concentrations stimulate upregulation of transporters SGLT2, SGLT1 and GLUT2 via 
hepatocyte nuclear factors (HNF)-1α and -3β (Freitas et al., 2008; Sabino-Silva et al., 2009; 
Figure 1.2). This increase in transporter expression causes an even greater reuptake of glucose 
into the PTC and back into systemic circulation. 
1.3.2.2 Proximal tubule cell growth in the presence of glucose 
 
This increased intracellular concentration of glucose not only increases the glucose transport, 
it also stimulates unique growth phenotypes within the PTC. Hyperglycaemia is known to 
increase the production of protein kinase C-beta (PKC-β) as well as growth factors, such as 
insulin-like growth factor-1 and vascular endothelial growth factor, which disinhibit 
mammalian target of rapamycin-C1 (mTOR-C1; Jetten et al., 1985; Hovis et al., 1986; 
Shantz, 2004). Both mTOR-C1 and PKC-β stimulate the increase of ornithine decarboxylase 
(ODC) (Jetten et al., 1985; Hovis et al., 1986; Shantz, 2004). ODC forms the rate limiting 
enzyme for the production of polyamines, which induce cell hyperplasia in the proximal 
tubule (Deng et al., 2003). After the early stage of hyperplasia, occuring at around four days 
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after streptozotocin induced diabetes in mice, PKC-β induces TGF-β1 which triggers the 
switch from hyperplasia to hypertrophy (Han et al., 2000; Huang et al., 2000; Deng et al., 
2003). Along with the upregulation of glucose transporters, this increase in cell number and 
size can further increase glucose reabsorption. At day ten in the STZ-induced diabetic mouse 
model, after significant cellular growth and expansion, TGF-β1 levels have been shown to rise 
(Satriano et al., 2010). The rise in TGF-β1 inhibits polyamines and induces cyclin dependent 
kinase inhibitors such as p21 which halt the cell cycle, inducing cellular senescence (Satriano 
et al., 2010). Senescent cells have been shown to increase release of inflammatory signals, 
growth factors and extracellular matrix as well as being resistant to apoptosis (Allen et al., 
1999; Sitte et al., 2000).  
1.3.3 Fibrosis and proximal tubule cells 
 
Glucose itself is described as profibrotic as it both increases the deposition of ECM and 
decreases the activity of proteolytic enzymes which break it down, such as those belonging to 
the matrix metalloproteinase family (Phillips et al., 1997; Brownlee, 2001). Increased 
intracellular glucose cause hyperactivity of the polyol and hexosamine pathways, resulting in 
the accumulation of reactive metabolites such as sorbitol and diacylglycerol (DAG) (Greene 
et al., 1987; Williamson et al., 1993; Phillips et al., 1997; Zhang et al., 1999; Brownlee, 
2001; Figure 1.3) 
1.3.3.1 The polyol pathway 
 
Glucose is reduced to sorbitol via aldose reductase in the polyol pathway. Increased sorbitol 
causes oxidative stress through pseudohypoxia, by unbalancing cellular reduction and 




 (Greene et al., 1987; Williamson et al., 
1993; Figure 1.3). Using the aldose reductase inhibitor tolrestat, Zhang et al. (1999) 
demonstrated that the glucose induced increase of PKC was attenuated. Sorbitol build up has 
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also been shown to activate the tissue inhibitor of metalloproteinases (TIMP)-1 and -2 
(Phillips et al., 1997). TIMP1/2 can consequently inhibit gelanolytic activity, decreasing 
degradation of type IV collagen and fibronectin and result in the accumulation of fibrotic 
deposition. Studies conducted in cultured human PTCs showed this effect could be eliminated 
by treatment with sorbinil, an aldose reductase inhibitor (Phillips et al., 1997). Sorbitol is also 
oxidised by NAD
+
 to form triose phosphate, which contributes to the formation of advanced 
glycation end-products (AGEs), and will be discussed later (Williamson et al., 1993; Figure 
1.3). The inhibitory effect on protein degeneration causes a significant increase in renal 
fibrosis without additional protein deposition in cultured human PTCs (Phillips et al., 1997). 
Oddly, metalloproteinase-2 (MMP-2) a gelanolytic enzyme was shown to be upregulated by 
TGF-β1 (Phillips et al., 1997; Kim et al., 2007). MMP-2 is a protease that has been linked to 
the breakdown of the BM and the cleaving of inhibitory binding proteins of stored TGF-β1 in 
the ECM via a PKC dependent pathway. Combining the inhibition from TIMPs with MMP-2s 
preferential breakdown of type IV collagen (the major structural component of BMs) focuses 
the breakdown of BM, over interstitial matrix. This disruption of the BM causes a loss of 
adhesion in PTCs, promoting further fibrosis and epithelial-mesenchymal transition (EMT; 
Yu & Stamenkovic, 2000; Kim et al., 2007). 
1.3.3.2 The hexosamine pathway 
 
The hexosamine pathway produces proteoglycans, glycolipids and glycoproteins from glucose 
via a series of reactions. The rate limiting enzyme is glutamine:fructose-6-phosphate 
amidotransferase (GFAT; Brownlee, 2001). The upregulation of this pathway through 
increased GFAT activity results in the production of DAG, a PKC activator which promotes 
the increase of TGF-β1 (Daniels et al., 2000; Figure 1.3). Both the polyol and hexosamine 




1.3.3.3 Advanced glycation end products 
 
Chronic hyperglycaemia causes an extensive build-up of AGEs, as well as increased triose 
phosphate formation from sorbitol metabolism (Williamson et al., 1993; Cohen et al., 2003; 
refer to Figure 1.3). AGEs are non-enzymatically glycated proteins which interact with the 
AGE receptor causing the increased expression of PKC and nuclear factor-kappa B (NF-κB) 
(Hofmann et al., 1999; Osicka et al., 2000). Kelly et al. (2001) subsequently provided 
evidence of the specific stimulation of TGF-β1 by AGEs. Treatment with aminoguanidine, an 
AGE formation blocker, attenuated the increase in TGF-β1 and type IV collagen associated 
with the Type I diabetic kidney of the (mRen-2)27 rats (Kelly et al., 2001). 
1.3.4 Adrenergic Receptors 
 
Increased sympathetic activity can form both a cause and consequence of renal damage (Joles 
& Koomans, 2004). Sympathetic hyperactivity increases systemic BP, which increases 
mechanical stress and pressure on the kidneys. However, sympathetic stimulation can directly 
contribute to renal damage by stimulating pathogenic pathways within the kidney (Kim & 
Padanilam, 2013). These pathogenic pathways have been attributed to the activation of 
adrenergic receptors by NA. 
1.3.4.1 α2-Adrenergic receptors 
 
Within the renal proximal tubule, the predominant adrenergic receptor is the α-adrenergic 
receptor (AR), with α2 the most common subtype (Calianos & Muntz, 1990). Kim & 
Padanilam (2013) found evidence that NA increased expression of TGF-β1 and 
tubulointerestitial fibrosis both in vivo and in vitro in the mouse and rate models. Pertinently, 
the the group went on to demonstrate that this fibrotic response is mediated through the α2-AR 
as selective α2-AR antagonists attenuated fibrotic deposition. However, the α2 subtype is 
historically noted as an inhibitor of neurotransmitter release via negative feedback at the 
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presynaptic terminal, suggesting that this inhibitory response may stem from extra-renal 
binding sites in the whole animal (Starke, 1972; Trendelenburg et al., 1994). The α2-AR is 
also known to protect against fibrosis and other pathogenic remodelling in heart failure 
(Gilsbach et al., 2010; Brede et al., 2002). In the diseased kidney, afferent renorenal 
inhibition of sympathetic neurons is reversed to become excitatory with the release of 
adenosine from stressed PTCs (Katholi et al., 1983; Katholi et al., 1984; Katholi et al., 1985). 
It may be that in vivo the excitation by afferent neurons provides enough stimuli to continue 
the release of NA even in the face of continued binding of the inhibitory pre-synaptic α2-AR 
(Figure 1.3). The continued release of NA will result in the activation of α2-AR on the PTCs, 
where the associated Gi protein inhibits adenylate cyclase decreasing cyclic AMP (cAMP); 
which is known to inhibit TGF-β and other pro-fibrotic signals (Schiller et al., 2010; Liu et 
al., 2006; Saltzman et al., 1982; Guller et al., 1994; Riquet et al., 2000; Figure 1.3). 
1.3.4.2 α1-Adrenergic receptors 
 
Besides Kim & Padanilam (2013), no other studies have confirmed or refuted α2-AR 
activation in renal fibrosis, therefore it is plausible that other ARs are involved. The next most 
prevalent receptor is the α1-AR, which is linked to the Gq protein (Calianos & Muntz, 1990). 
The Gq protein phosphorylates phospholipase C (PLC) which then upregulates DAG and 
causes a rapid increase in intracellular calcium (Ca
2+
). DAG then activates PKC in the 
presence of high intracellular Ca
2+
 (Chung et al., 1998). As noted earlier, increased PKC 
stimulates a variety of pro-fibrotic proteins including TGF-β1 (refer to Figure 1.3).  
NA has been shown to directly stimulate gluconeogenesis through the α1-AR in a range of 
animal species kidneys (Nakada et al., 1986; Kessar & Saggerson, 1980; Guder & Rupprecht, 
1975; Kessar & Saggerson, 1980; Kurokawa & Massry, 1973; MacDonald & Saggerson, 
1977; Nakada et al., 1986; Roobol & Alleyne, 1973). However, Conjard et al. (2001) was 
unable to detect this stimulatory effect of NA in human PTCs. A more recent study by Meyer 
17 
 
et al. (2003) supported Conjard et al. (2001) stating that “the increase in renal gluconeogenic 
efficiency that we found might have been indirectly mediated.” Both papers argued that 
another factor such as the increase of free fatty acids by NA, could have stimulated an 
increase in gluconeogenesis. Conjard et al. (2001) also criticised past in vitro studies deeming 
the level of Ca
2+
 used below physiological concentrations, potentially causing an increase in 
gluconeogenesis. There is evidence for an increase in Na
+
 reabsorption due to NA in the 
proximal tubules of humans (Lang et al., 1993). Increased Na
+
 reabsorption was linked to the 
activation of the α1-AR (Hesse & Johns, 1985). This effect had been well recorded in animal 









-ATPase is found on the 
basolateral side of PTCs, and transfers three Na
+
 ions from inside the cell to the interstitium in 
exchange for two K
+ 
ions in the opposite direction (Beach et al., 1987). This removal of Na
+
 
from inside the cell produces the concentration gradient used to transport Na
+
 from the tubular 
lumen into the cell. The SGLT proteins take advantage of this Na
+
 gradient to pump more 
glucose and Na
+





-ATPase more glucose is able to be drawn into the cell alongside 
Na
+
. This could further add to the hyperglycemic stress experienced by the cells, increasing 
the production of TGF-β1 and other profibrotic cytokines (Greene et al., 1987; Williamson et 
al., 1993; Zhang et al., 1999; Daniels et al., 2000). 
1.3.4.3 β-Adrenergic receptors 
 
The β-ARs populations are comparatively fewer in number than the α-ARs within the 
proximal tubules, and are consequently considered unlikely to be responsible for the increase 
in TGF-β release (Calianos & Muntz, 1990; Hanson et al., 1995). β-AR are predominantly 
coupled to the Gs protein which acts in an opposite fashion to the Gi; activating adenylate 
cyclase to upregulate cAMP and inhibiting activation of extracellular signal-regulated kinase 
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1/2 and Smad recruitment of transcriptional coactivators, both TGF-β1 induced and mediated 
profibrotic pathways (Schiller et al., 2010; Liu et al., 2006; Saltzman et al., 1982; Guller et 
al., 1994; Riquet et al., 2000; Figure 1.3). Although the β2-AR subtype can also be coupled to 
the Gi protein; due to the scarce numbers of β2-AR within the proximal tubule it is unlikely 
that this receptor has a pathological role in this context (Hanson & Linas, 1995). 
The β1-AR, as noted earlier, can increase the release of intrarenal renin, ultimately resulting in 
increased Ang II in the proximal tubule (Choi et al., 1997; Kelly et al., 2000; Zimpelmann et 
al., 2000; refer to chapter 1.2.1.3). Like the α1-AR the AT1 receptor is coupled to a Gq protein, 
thus increased Ang II will promote the increase in PKC and TGF-β1 through the same 
activation pathway (Griendling & Alexander, 1993; Chung et al., 1998; refer to Figure 1.3) 
1.3.5 TGF-β1 as a fibrotic marker 
 
TGF-β and its downstream Smad signalling are accepted as key pathway instigators of renal 
fibrosis (Bhandari et al., 2002). TGF-β has three subtypes; TGF-β1, TGF-β2 and TGF-β3. The 
TGF-β1 isoform is the most common and heavily researched (Ding & Choi, 2014). The 
expression of TGF-β1 is predominantly induced through the upregulation of PKC (Chen et al., 
2001). Increased TGF-β1 expression is caused by a range of stress inducers like those 
commonly experienced in DN such as hyperglycaemia, Ang II, AGEs and oxidative stress 
(Rocco et al., 1992; Rumble et al., 1997; Gruden et al., 1999; Wolf, 2000, Xu et al., 2012). 
TGF-β1 acts through both autocrine and paracrine pathways to activate three isoforms of the 
TGF-β receptor (Ziyadeh et al., 1994). TGF-β type I, II and III transmembrane receptor 
serine/threonine kinases have all been shown to possess high affinity for TGF-β1 (Dore et al., 
1998). These receptors phosphorylate Smad 2/3, which then binds to Smad4 (Bottinger & 
Bitzer, 2002; refer to Figure 1.3). These complexes then translocate into the nuclei, from 
which they regulate the transcription of TGF-β1 responsive genes, inducing effects such as 
senescence, hypertrophy, pro-apoptotic signalling, increased ECM deposition, activation of 
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fibroblasts and epithelial-mesenchymal transition of proximal tubule cells. The activation of 
TGF-β receptors stimulates the expression of TGF-β1, accounting for the overexpression in 
chronic injuries due to a cycle of upregulation (Wolfman et al., 2003; Xu et al., 2012; Kato, 
2013). The role of Smad4 in TGF-β1 induced fibrosis found that cell lines deficient in Smad4 
still continued to over-express ECM. Due to Smad4 being crucial for Smad signalling this 
suggests that TGF-β1 has both Smad-dependent and independent pathways for pro-fibrotic 
signalling. 
 
Figure. 1.3 Simplified schematic of fibrotic signalling pathways as a result of hyperglycemia and 
adrenergic activation in diabetic nephropathy. Theoretical pathways of interaction between glucose 
and noradrenaline. GFAT: Fructose-6-phosphate amidotransferase; AGE: Advanced glycation end 
product; DAG: Diacylglycerol; PKC: Protein Kinase C; TGF-β: Transforming growth factor; AR: 












1.4 Epithelial-mesenchymal transition 
 
As noted earlier one of the many pathways TGF-β1 promotes is EMT, this is defined as the 
loss of PTC epithelial phenotype and the acquisition of mesenchymal characteristics (Liu, 
2004). These changes result in the disruption of the tubular basement membrane due to the 
loss of polarity, E-cadherin, cell adhesion and a range of adjacent cell signals (Hills et al., 
2012). EMT is indicative of cellular damage, coinciding with interstitial fibrosis in 
nephropathy (Kalluri & Neilson, 2003; Kalluri & Weinberg, 2009; Thiery et al., 2009; Kriz et 
al., 2011). TGF-β induces EMT by silencing epithelial phenotypes such as E-cadherin 
expression through hypermethylation of their promoters. Papageorgis et al. (2010) confirmed 
this by disrupting TGF-β1 dependent Smad 2 signalling by stably overexpressing the 
inhibitory Smad 7. The lack of TGF-β-Smad 2 signalling led to the demethylation of these 
promoters and re-expression of the phenotypes. 
EMT has been controversially suggested to result in differentiation to another mature cell 
type, primarily fibroblastic, therefore directly increasing fibrosis (Iwano et al., 2002). TGF-β1 
had been reported to promote the expression of α-smooth muscle actin (SMA), an indicator of 
myofibroblast (a fibroblastic cell attributed to EMT) formation (Runyan et al., 2009).  
In vivo studies have been less clear about the transformation of EMT cells. Iwano et al. (2002) 
was one of the first and only in vivo studies to trace fibroblasts back through cell markers to 
epithelial cells. Humphreys et al. (2010) repeated the same experiment on mice and found no 
epithelial trace in the fibroblasts. Unlike Iwano et al. (2002), Humphreys et al. (2010) used 
high-resolution cell fate tracking to determine lineage of fibroblasts to PTCs. They concluded 
that previous data like that produced by Iwano et al. (2002) was most likely a result of 
antibody staining creating false positives, compared to their method of measuring enzymatic 
activity. Similarly, cell fate tracking has been used to investigate the veracity of FSP-
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1/S100A4 expression as a marker for fibroblasts, and these results also showed a lack of cell 
specificity (Strutz et al., 1995; Le Hir et al., 2005; Lin et al., 2008).  
With the majority of research disagreeing with a full transition of epithelial cells to fibroblasts 
through highly advanced cell fate tracing, it is unlikely this is responsible for the increase in 
ECM seen in kidney injury or DN (Humphreys et al., 2010; Koesters et al., 2010; Li et al., 
2010). However, more in vivo studies are necessary to fully determine the extent of EMT. It is 
recognised a change in epithelial markers occurs in renal injury and under TGF-β1 
stimulation. Therefore, it is highly possible EMT does not result in full transition to 
fibroblasts but still has a major influence on fibrosis by compromising the integrity of the 
tissue encouraging fibrosis in order to stabilise the BM. It has been seen that mice suffering 
renal injury overexpress the profibrotic protease MMP-2 which is known to preferentially 
break down BM, causing increased disruption and loss of adhesion to PTCs (Rastaldi et al., 
2002). This preferential break down of the BM has been seen in biopsies of human kidneys 
from chronic kidney disease patients (Cheng et al., 2006). It is thought that as the cells change 
towards a mesenchymal phenotype internal metabolic changes may result in an upregulation 
of production and secretion of profibrotic cytokines, similar to the changes seen in senescent 
cells (Allen et al., 1999; Sitte et al., 2000). 
1.5 Glucose and noradrenaline 
 
Glucose had previously been seen to increase collagen production through the induction of 
TGF-β1 (Rocco et al., 1992). Subsequent studies have shown that while glucose does increase 
transcription of TGF-β1, it predominantly acts to prime cultured cells for a secondary signal to 
stimulate the translation and activation of TGF-β1. Both interleukin 1 and platelet-derived 
growth factor (PDGF) are known to stimulate the increase in translation and ultimately 
secretion of active TGF-β1 (Phillips et al., 1995; Phillips et al., 1996; Fraser et al., 2003). 
Little is known on these exact mechanisms, however it is thought that glucose sensitises the 
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cell to PDGF signalling increasing responsiveness (Fraser et al., 2003). As noted previously, 
NA has shown a similar quality in upregulating the fibrotic response through TGF-β1 
pathways in renal injury (Kim & Padanilam, 2013). 
1.6 Rationale and Aims 
 
DN is an encroaching issue due to the ever expanding diabetic population, predominantly 
caused by a range of lifestyle factors. Our knowledge of DN is increasing, as more attention 
focuses on treatment, prevention and understanding of the pathology to reduce the potential 
cost of ESRD both in monetary terms and human life. The impact tubulointerstital fibrosis has 
on renal function has been recognised as one of the best indicators for the progression and 
outcome of the patients, this has presented a range of potential therapeutic targets in order to 
minimise the progression.  
Although glucose can stimulate fibrosis independently in diabetes via TGF-β, its synergistic 
relationship with a range of molecules has been of greater interest, such as NA. Recently renal 
denervation has been investigated for its anti-fibrotic potential outside of haemodynamic 
influences. Kim and Padanilam (2013) found the α2-AR was responsible for the increased 
TGF-β1 and collagen levels in renal injury, however, mechanistically the literature better 
supports α1-AR as the modulating receptor. α1-AR has the potential to increase TGF-β1 
directly through pathways such as the upregulation of PKC by the Gq protein, as well as 
increasing the glycaemic load on cells by enhancing glucose reabsorption and potentially 
initiating gluconeogenesis.  
As the synergistic relationship of NA and glucose has only recently begun to be investigated 
literature on the specific interactions is very limited. While theoretical pathways and 
mechanisms can be devised, more in vitro and in vivo investigation is required to fully 
determine which receptors are involved and what their roles in the upregulation of pro-fibrotic 
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signalling are. Therefore, the aims of this research study were to develop an in vitro protocol 
replicating the conditions of a hypertensive diabetic in the proximal tubule. From here the 
study then aimed to determine any synergistic effect of glucose and NA on TGF-β1 secretion, 
as well as determine the responsible adrenergic receptors. This study was designed to clarify 
the pathways involved in DN, providing a base from which further DN fibrosis pathways can 
be investigated as well as targeted treatments which can be developed to minimise or prevent 
injury. 
1.6.1 Cell Lines 
 
The HK-2 (ATCC® CRL-2190) cell line is a human PTC line from a healthy adult kidney, 
which has been transfected with the E6/E7 genes from the human papilloma virus (HPV 16) 
to immortalise the cell line. This was chosen as the primary cell line due to being able to 
reproduce experimental results obtained with freshly isolated PTCs (Ryan et al., 1994).  
The Madin-Darby canine kidney (MDCK) cell line (ATCC® CCL-34) is a canine kidney 
epithelial cell line harvested from a healthy adult female cocker spaniel. This cell line was 
used to its close phenotypic resemblance to HK-2, as a positive control for cell culture 




Based on current literature, this study hypothesised that human proximal tubule cells exposed 
to NA in the presence of high glucose concentration will express increased levels of TGF-β1, 
compared to either NA or glucose individually. The study was consequently designed to test 
the theory that, this increase in TGF-β1 is modulated through the α1-AR.  
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2 Materials and Methods 
2.1 Materials and Equipment 
 
A list of all the chemicals and reagents used in this project are presented in Table 2.1, unless 
stated otherwise. All deionised water was sourced from a Milli-Q Ultrapure Water 
Purification System (Merck Millipore, Billerica, MA, USA). Cell culture work was conducted 
in a Safe 2020 Class II Biological Safety Cabinets (Thermo Scientific, Rockford, IL, USA)  
and cells incubated in a Heraus HERAcell
TM
 150 incubator (Thermo Scientific, Rockford, IL, 
USA), centrifugation in a 5810 R Centrifuge (Eppendorf, Hamburg, DEU) and -80 °C attain 
in a Sanyo VIP Series -86C Ultra-Low Temperature Freezer (SANYO Electrical, Osaka, 
JPN). 
Table 2.1 List of chemicals and reagents used 
Material Supplier Location 
Absolute Ethanol Scharlau Sentmenat, CT, ESP 
Blocking Buffer Prepared in the lab see Appendix 
Bovine Serum Albumin Sigma-Aldrich St. Louis, MO, USA 
DC Protein Assay Kit Bio-Rad Hercules, CA, USA 
Carbon Dioxide Gas BOC Gases New Zealand LTD Dunedin, NZ 
Cell Culture Lysis Buffer Prepared in the lab see Appendix 
Cryogenic Freezing Media Prepared in the lab see Appendix 
D-(+)-Glucose Sigma-Aldrich St. Louis, MO, USA 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich St. Louis, MO, USA 
DL-Norepinephrine 
hydrochloride 
Sigma-Aldrich St. Louis, MO, USA 
D-Mannitol Sigma-Aldrich St. Louis, MO, USA 
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Material Supplier Location 
Donor Bovine Serum (DBS) South Pacific Sera Timaru, NZ 
Dulbecco’s Modified Eagle’s 
Medium (DMEM) 
Life Technologies Carlsbad, CA, USA 
Dulbecco’s Modified Eagle’s 
Medium and Ham’s F12 
Medium (DMEM/F12) 
Life Technologies Carlsbad, CA, USA 
Foetal Bovine Serum (FBS) Life Technologies Carlsbad, CA, USA 
Kaleidoscope Prestained 
Standard 
Bio-Rad Hercules, CA, USA 
Low Fat Milk Powder Pams, Foodstuffs Wellington, NZ 
NuPAGE® Antioxidant Life Technologies Carlsbad, CA, USA 
NuPAGE® LDS Sample 
Buffer 
Life Technologies Carlsbad, CA, USA 
NuPAGE® MOPS SDS 
Running Buffer 
Life Technologies Carlsbad, CA, USA 
NuPAGE® Reducing Agent Life Technologies Carlsbad, CA, USA 
Penicillin-Streptomycin Life Technologies Carlsbad, CA, USA 
Peroxidase Goat Anti-Rabbit 
Polyclonal IgG: 32460 
Thermo Scientific Pierce Protein 
Biology Products 
Rockford, IL, USA 
Phosphate Buffered Saline 
(PBS) 
Prepared in the lab (see Appendix A) 
Poly-L-lysine (PLL) Sigma-Aldrich St. Louis, MO, USA 
Ponceau S Solution Sigma-Aldrich St. Louis, MO, USA 
Protease Cocktail Inhibitor Sigma Aldrich St. Louis, MO, USA 
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Material Supplier Location 
SuperSignal® West Dura 
Extended Duration Substrate 
Thermo Scientific Pierce Protein 
Biology Products 
Rockford, IL, USA 
TGF-β1 (V) Antibody: sc-146 Santa Cruz Biotechnology Inc. California, CA, USA 
Tris Buffered Saline Prepared in the lab (see Appendix A) 
Trypsin-EDTA (0.05%) Life Technologies Carlsbad, CA, USA 
Tween20 Sigma-Aldrich St. Louis, MO, USA 
Tween20-Tris Buffered Saline 
(TTBS) 
Prepared in the lab (see Appendix A) 
 
2.2 Cell Culture 
 
2.2.1 Growth media 
 
HK-2 cells (CRL-2190, American Type Culture Collection, Manassas, VA, USA) were 
cultured in a 1:1 mixture of sterilise Dulbecco’s modified Eagle’s medium (DMEM) and 
Ham’s F12 nutrient mixture (DMEM-F12) containing L-glutamine (2.5 mM), sodium 
bicarbonate (2.438 g/L) and phenol red (8.1 mg/L). The media was supplemented with 10% 
donor bovine serum (DBS; South Pacific Sera, Timaru, NZ).  
The MDCK cell line (CCL-34, American Type Culture Collection, Manassas, VA, USA) was 
grown in sterile DMEM containing D-glucose (4.5 g/L), L-glutamine (2.5 mM), sodium 
pyruvate (110 mg/L) and phenol red (8.1 mg/L); and supplemented with 2% DBS. Both 





2.2.1.1 Serum Adaptation 
 
Both cell lines were initially grown in media supplemented with foetal bovine serum (FBS; 
Life Technologies, Carlsbad, CA, USA), and adapted to DBS before experiments began. Cells 
were grown from a fresh passage in their respective medias supplemented with 7.5% FBS and 
2.5% DBS. They were grown in this media for two passages at which point the medium was 
changed to a supplementation of 5% FBS and 5% DBS. This serum supplement was 
sequentially changed to a 2.5% FBS/ 7.5% DBS mixture before finally reaching 10% DBS. 
HK-2 cells were grown in this final DBS concentration throughout the rest of experiments 
unless stated otherwise. The MDCK cells were grown in a final growth supplement 
concentration of 2% DBS using the same protocol as above. Between each passage and 
growth phase cells, were examined and photographed under an optical microscope to ensure 
morphological structure and growth times were comparable to cells grown in the original 
serum concentrations. 
2.2.2 Cell Culture Maintenance 
 
HK-2 cells were grown at 37 °C, with 5% CO2 in growth media detailed in chapter 2.2.1. The 
growth media was changed every four days and cells were passaged approximately every six 
days, once reaching 80% confluency. At 80% confluency, the HK-2 cells numbered 
approximately 2x10
6 
cells per T75 flask. The HK-2 cells used never exceeded 30 passages. 
MDCK cells were grown under the same conditions in their respective growth media (as seen 
in chapter 2.2.1), cells were passaged every four days, however if not 80% confluent by the 
fourth day the media was changed and normally passaged within two days of media change. 
Following decanting of the used media from the flasks, the cells were passaged by washing 
with 5 mL of warmed phosphate buffered saline (PBS) and decanted in order to remove any 
residual protein. 3 mL of trypsin-EDTA (0.05%). The flasks were returned to the incubator 
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for five minutes. Cell dissociation was checked under an optical microscope and once visibly 
dissociated 4 mL of growth media was added to the Trypsin suspension. The bottom of the 
flask was gently aspirated with the combined solution in order to wash all of the cells off. The 
cell suspension was transferred to 15 mL centrifuge tubes. The flasks were again checked 
under the optical microscope in order to confirm all the cells had been transferred. The cell 
suspension was then pelleted in a centrifuge at 1500 rpm (4 °C) for 5 minutes.  The 
supernatant was removed and the pellet resuspended in 4 mL of growth media at 37 °C. T75 
flasks where sub-cultured with 1 mL of this suspension as recommended by the ATCC 
guidelines. 
2.2.3 Cryogenic Preservation 
 
Cells where trypsinised and pelleted as described (as seen in chapter 2.2.2). Cell pellets were 
resuspended in ice cold cryogenic media containing dimethyl sulfoxide (DMSO; Appendix 
A). Suspended cells (1 mL) were aliquoted into each cryo-vial, and stored in a 5100 Cryo 1 
°C Freezing Container (Thermo Scientific, Rockford, IL, USA) in a -80 °C freezer overnight. 
Cryo-vials were then transferred into a liquid nitrogen tank for long term storage. The success 
of the cell storage protocol was confirmed by thawing and regrowing the cryopreserved cells 
after storage (as detailed in chapter 2.2.4). 
2.2.4 Thaw Procedure 
 
Cryo-vials containing cell aliquots were thawed quickly in a 37 °C water bath until only the 
core remained frozen. Once the core had melted outside of the water bath, the contents of the 
cryo-vial were divided into two labelled T25 cell culture flasks. Growth media (4.5 mL, 37 
°C) was added to each flask. Cells were inspected using an inverted microscope for 
morphology, and then placed in an incubator at 37 °C with 5% CO2. Media was changed as 
soon as cells adhered in order to remove the DMSO. Once cells had become 80% confluent, 
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cells were passaged as seen in chapter 2.2.2 using 1.5 mL of trypsin and growth media. The 
suspended cells from each T25 were split into two new T75 flasks. 
2.2.5 Cell Counting 
 
The cell pellet was resuspended with 4 mL of media in a 15 mL centrifuge tube. A Mod. 
Fuchs-Rosenthal haemocytometer (Weber, UK) was cleaned and a coverslip firmly placed on 
top to display Newton’s rings. 30 μL of the resuspended cell pellet was added to the 
haemocytometer chamber through capillary action. The haemocytometer was then viewed 
under a 10x objective of an optical microscope, each cell within the corner grids of the main 
grid were counted. The mean number of cells from the grids was multiplied by 10,000 to give 
the number of cells/mL. If the mean cell number counted exceeded 200, then a 10 μL of cell 
suspension was diluted in 90 μL of PBS and recounted.  
2.2.6 Treatment 
 
Table 2.2 Glycaemic Treatment Groups 
Glycaemic treatment groups Additional supplements to serum free growth media 
Control - 
Normoglycaemic 6.1 mmol/L D-glucose 
Hyperglycaemic 25 mmol/L D-glucose 
Osmotic Control 6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol 
 
2.2.6.1 Initial Treatment Protocol 
 










 cells per well) 
where tested in 24 well plates in order to establish a confluent monolayer in 24 hours. From 
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these pilot studies a seeding density of 7.5x10
4
 was selected and suspended in 500 μL of 
growth media per well. 
After 24 hours the growth media was aspirated and the well was gently washed with 200 μL 
of warmed PBS. The PBS was then aspirated and 500 μL of serum free media added, in order 
to arrest growth in the cells over 6 hours. After 24 hours, serum free media was replaced with 
treatment media (see Table 2.2). NA was added to the treatment media in the well, with the 
final concentration of 1 nM. Because ascorbic acid was used to prevent NA oxidisation a set 
of controls were carried out with a final concentration of 0.1 nM ascorbic acid, alongside a 
vehicle (PBS) control. The cells were treated for 48 hours before being harvested. 
The conditioned media was harvested and stored at -20 °C in 1.7 mL microcentrifuge tubes 
with 5 μL of Protease Cocktail Inhibitor. The 24 well plates were washed with PBS and 
placed onto ice. 100 µL of cell lysis buffer (Appendix A) was added to each well. Falcon® 
(Corning Inc., Corning, NY, USA) cell scrapers were used to dislodge the cells from the 
bottom of the wells. The cell lysate was then transferred to 1.7 mL microcentrifuge tubes 
which were stored at -20 °C until required.    
The conditioned media was frozen down to -80 °C for a minimum of 2 hours and freeze dried 
(TFD5503 Laboratory Freeze Drier, ILSHIN BIOBASE Co., Ltd., KR) for 48 hours to 
lyophilise protein. The freeze dried protein was resuspended in 300 μL of deionised water and 
sonicated (Vibra-Cell
TM
 VC 750 Sonicator, Sonics and Materials, Newtown, CT, USA) using 
three 7 second bursts, while keeping samples on ice. 
2.2.6.2 Optimisation of Treatment Protocols to establish a Confluent Monolayer 
 
Due to cell damage suffered during the wash stages (Appendix B), the above protocols were 
revised in order to produce a confluent and continuous monolayer. All other sections of the 
experiment remained the same apart from those mentioned in each step below. 
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2.2.6.3 Seeding Density and Growth Time 
 








 cells per well. Different 
cell growth times were also attempted, varying from the original 24 hours to include 12 and 






 cells per well. These 
experiments were carried out to see if confluency played a part in the cell survival. 
2.2.6.4 Wash Solutions 
 
Cell washes with fresh PBS as well as serum free growth media were compared in parallel 





per well, in order to see if wash solution was responsible for damage. 
2.2.6.5 Growth Arrest Time and Media 
 
Growth arrest time was increased from 24 to 48 hours, the serum free media was also 
compared to low serum (2% Donor Calf Serum) media for the growth arrest period. This was 
conducted in order to see if increasing recovering time would increase cell survival. 
2.2.6.6 Well Plate Surface 
 
A different brand of 24 well cell culture plate (Falcon; Corning Inc., Corning, NY, USA) was 
compared against the original plate brand (BIOFIL; JET Bio-Filtration Products Co., Ltd. 
Guangzhou, CN), at a seeding density of 2x10
5
 cells per well. This was in order to rule out the 
plate surface as responsible for the apparent damage. Original brand plates were also coated 
with poly-L-lysine (PLL; seeded with 1x10
5
 cells per well) and compared to their non-coated 





2.2.6.7 Increasing Well Size 
 
The well size was increased by using 12 well culture plates and 100 mm culture dishes seeded 
at 2x10
5
 cells per mL. The 12 well culture plates were seeded using 1 mL per well of cell 
suspended growth media, the 100 mm dish received 10 mL of the cell suspension.  These 
were compared against the 24 well plate seeding equivalent in order to see if increasing well 
and monolayer surface area increased the survivability of cells. 
2.2.6.8 Changing Serum Type 
 
The serum of the growth media was switched back to the original FBS and used in 12 well 
plates seeded at 2x10
5
. This was compared against DBS growth media, to ascertain if DBS 
lacked nutrients resulting in reduced survival of HK-2 cells. 
2.2.6.9 Increasing Protein Harvest for Optimised Treatment Protocol 
 
Experiments were carried out using 100 mm culture dishes to increase amount of harvested 
conditioned media and cell lysate, to increase amount of TGF-β1 present for western blotting. 
HK-2 cells were seeded at 2x10
6
 cells per dish in 10 mL of FBS supplemented growth media. 
The cells were left for 48 hours at which time they were 90-100% confluent. The growth 
media was then aspirated and washed with 2 mL of PBS, before being replaced with serum 
free media (DMEM/12). The cells were growth arrested for 24 hours then serum free media 
was aspirated and exposed to treatment conditions (see Table 2.2) for 48 hours. The 
conditioned media and cell lysate were harvested as presented in chapter (see chapter 2.2.6.1), 
with the exceptions of conditioned media being stored in 15 mL centrifuge tubes with 80 μL 
of Protease Cocktail Inhibitor and cell lysate harvested using 1 mL of cell lysis buffer (see 




2.2.7 Western Blotting 
 
Western blotting and the quantification of protein were carried out to assess the change in 
expression of the pro-fibrotic marker TGF-β1. An increase in TGF-β1 would indicate the 
potential influence of PTCs on fibrosis in DN.  
2.2.7.1 Protein Concentration Assay 
 
The Bio-Rad DC Protein Assay (Bio-Rad, Hercules, CA, USA) was used to colourimetrically 
measure the protein concentration of thawed lysate samples. The DC protein assay is derived 
from the Lowry assay to provide faster and more stable reactions of protein and copper in an 
alkaline medium. The copper-treated protein reduces the Folin reagent to produce a blue 
colour which has can be quantified by measuring the absorbance at λ=750 nm. This colour 
change is directly proportional to the protein concentration. 
Seven standards were prepared by diluting lypholysied Bovine Serum Albumin (BSA) in cell 
culture lysis buffer at the concentrations of 0 (blank), 0.1, 0.2, 0.3, 0.5, 1.0 and 1.5 mg/mL. 
The protocols and working reagents were provided by the manufacturer (Bio-Rad, Hercules, 
CA, USA). Working reagent A was prepared by adding 20 μL of reagent S (surfactant 
solution) to every 1 mL of reagent A (alkaline copper tartrate solution) used. After vortexing, 
5 μL of standards and samples were added in triplicates to a clear 96 well plate, with 20 μL of 
working reagent A and 200 μL of reagent B (dilute Folin reagent) added to each well. After 
incubating for 15 minutes at room temperature the plate was read using a spectrophotometric 
plate reader (Benchmark Plus Microplate Spectrophotometer, Bio-Rad, Hercules, CA, USA) 
Sample concentrations were extrapolated to mg/mL in Prism
TM
 v.6 6 (GraphPad Software 




2.2.7.2 Sample preparation and loading 
 
After sample protein concentrations were determined (see section 2.2.7.1), samples were 
normalised to the lowest protein concentration available across all the samples. Samples were 
diluted using deionised water, NuPAGE® LDS Sample Buffer and NuPAGE® Reducing 
Agent in a volume ratio of 6.5: 2.5: 1, in order to denature and reduce the sample protein. The 
samples were then incubated for 10 minutes at 70 °C. 
TGF-β1 is a 25 kDa protein therefore NuPAGE® 4-12% Bis-Tris gels (Life Technologies
TM
, 
Carlsbad, CA, USA) were chosen as they had optimal separation for <60 kDa proteins. After 
opening the gel was placed into the XCell SureLock
TM
 Mini-Cell system (Life 
Technologies
TM
, Carlsbad, CA, USA), the inner cathode chamber was filled above the gel 
wells (200 mL) with NuPAGE® MOPS SDS Running Buffer. The first gel well was loaded 
with 10 μL of the Kaleidoscope Prestained Standards. Samples (15 μL) were loaded into each 
well, the final well was loaded with a 2.5 mg/mL protein sample of homogenised kidney 
cortical tissue isolated from a rat with diabetic nephropathy. This tissue had previously been 
demonstrated to contain TGF-β1 and acted as a positive control (Yao et al., 2014).  
2.2.7.3 Gel electrophoresis 
 
The inner cathode chamber in the XCell SureLock
TM
 Mini-Cell system had 500 μL of 
NuPAGE® Antioxidant (Life Technologies
TM
, Carlsbad, CA, USA) added to 200 mL of 
NuPAGE® MOPS SDS Running Buffer. This was performed in order to allow the 
antioxidant to migrate alongside the proteins, preventing reoxidisation. The outer anode 
chamber was then filled with NuPAGE® MOPS SDS Running Buffer. The XCell 
SureLock
TM
 Mini-Cell system was connected to the ZOOM® Dual Power Supply unit (Life 
Technologies
TM






The iBlot® Dry Blot System (Life Technologies
TM
, Carlsbad, CA, USA) was used to transfer 
migrated proteins from the resolving gel to a polyvinylidene difluoride (PVDF) membrane. 
The gel was removed from the plastic cassette and placed face down on the iBlot® Anode 
Stack (Life Technologies
TM
, Carlsbad, CA, USA). iBlot® Filter Paper (Life Technologies
TM
, 
Carlsbad, CA, USA) was soaked in deionised water and placed on top of the gel. The iBlot 
Cathode Stack (Life Technologies
TM
, Carlsbad, CA, USA) was placed on top of the filter 
paper and the bubbles between the layers were carefully removed. The proteins were then 
transferred from the gel to the PVDF membrane using the iBlot® Dry Blot System set to 20 V 
for 7 minutes.  
2.2.7.5 Immunoblotting 
 
The PVDF membrane was then washed in Tris-buffered saline (TBS; see Appendix A). 
Ponceau red was poured onto the membrane in order to establish protein transfer. The 
membrane was washed until the membrane no longer stained by the red ponceau. The 
membrane was treated with blocking solution (see Appendix A) for 2 hours at room 
temperature, to inhibit non-specific IgG binding. The membrane was washed three times in 
Tween20-TBS (TTBS, see Appendix A; 5 minutes). 
After the blocking solution had been washed away the membrane was incubated with anti-
TGF-β1, diluted at a 1:400 with TBS containing 0.1% BSA over night at 4 °C. Following the 
incubation the membrane was washed three times in TTBS (5 minutes) before being exposed 
to the horseradish peroxidase conjugated goat anti-rabbit polyclonal IgG (diluted to 1:1000 in 
TBS containing 5% milk powder). The membrane was left to incubate in the secondary 
antibody for 1 hour at room temperature. The secondary antibody was washed off with one 5 
minute wash in TTBS followed by three 5 minute washes in TBS.  
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2.2.7.6 Blot development 
 
Protein bands were detected using SuperSignal® West Dura Extended Duration Substrate. 
The enhanced chemiluminescent (ECL) substrates were mixed in equal proportions (800 mL 
each). The membrane was exposed to the ECL for 5 minutes and then placed between 
transparent plastic sheets in a Hyperfilm cassette (Amersham Bioscience, Buckinghamshire, 
UK). Hyperfilm ECL sheets (Amersham Bioscience, Buckinghamshire, UK) were exposed to 
the membrane for 10 seconds while pressed within the cassette. After exposure the Hyperfilm 
ECL sheet was developed using an All-Pro Imaging System (All-Pro 100, Hicksville, NY, 
USA).  
2.2.8 Statistical analysis 
 
Statistical analysis was performed using Prism
TM
 v.6.00 (GraphPad Software Inc., La Jolla, 
CA, USA). 
2.2.8.1 Effects to Cell Survival Grade 
 
Data which used the cell survival grade including the effect of seeding density, wash 
solutions, growth arrest period, growth period, well surfaces, serum type and growth surface 
area used ordinal data. Because of this the distribution of data needed to be analysed for 
normality. The primary independent variable such as seeding density or wash solution had 
four treatment groups (see Table 2.2) within them. Unfortunately these treatment groups were 
too small to analyse for normality, so were aggregated together to form the primary 
independent variable groups. These primary groups were then analysed using a D’Agostino & 
Pearson omnibus normality test, of which every group failed. As a result of the data being 
ordinal and failing to be normally distributed data analysis was conducted using 
nonparametric equivalent tests. 
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Ideally this data would have been analysed using a two-way ANOVA but due to requiring a 
nonparametric equivalent the data was analysed in two stages. Initially the treatment groups 
were analysed against one another within the primary groups. Once the effect of treatment on 
cell survival grade was known the treatment groups would then be aggregated again into 
primary groups, and the primary groups would be compared to one another. Because this 
required the nonparametric equivalent of a one-way ANOVA they were analysed using a 
Kurskal-Wallis test with a Dunn’s post-hoc to determine the effect of the primary groups on 
cell survival grade.    
2.2.8.2 Well Protein Concentration against Seeding Density 
 
Even though the data collected was not ordinal it was analysed via the D’Agostino & Pearson 
omnibus normality test like the rest, to confirm that the data was normally distributed, which 
it was. 
The treatment groups were not independently analysed before the seeding densities as a two-
way ANOVA with Bonferroni post-hoc was used to analyse the data. This allowed for both 
the effects of the treatment and seeding density on protein concentration to by analysed 
simultaneously, as it was possible to use a two-way ANOVA to assess the effect of treatment 
on well protein concentration. 
2.2.8.3 Correlation of Well Survival Grade to Well Protein Concentration 
 
The data collected from the effects of seeding density on cell survival grade and protein 
concentration were paired and matched before being correlated using the Spearman’s Rho 





2.2.8.4 Effect of different Wash Solutions on Survival Grade 
 
For the survival grade data, a D’Agostino & Pearson omnibus normality test was conducted, 
as before the data failed to be normally distributed. Because the data was both ordinal and not 
normally distributed the nonparametric equivalence of a t-test the Wilcoxon matched-pairs 



















3.1 Optimising Protocols to Increase Monolayer Survival 
 
The first section of this study involved optimisation of the cell culture protocol to reduce the 
extent of damage observed in the cell monolayer during washing and media change. 
3.1.1 Well Survival against Seeding Density 
 






) were associated with a significantly 





 density did not significantly increase cell survival, the lower seeding 
density of 1x10
5
 resulted in a 3.16-fold increase in survival grade compared to 7.5x10
4
 (1.04 
± 0.30 at 7.5x10
4 
vs 3.29 ± 0.26 at 1x10
5
, P<0.05). The two highest seeding densities did not 
differ significantly in their cell survival (4.54 ± 0.17 at 2x10
5
 vs 5.00 ± 0.00 at 2.5x10
5
, 




 caused a 4.36 and 4.80-fold increase in 





Cells grown in normoglycaemic and hyperglycaemic conditions after growth arrest showed no 
significant difference in survival as a consequence of treatment within any of the seeding 




Figure 3.1 The effect of seeding density on cell survival grade in HK-2 cells subjected to 
normoglycaemic and hyperglycaemic conditions. Cells were seeded at the indicated densities in 24 
well plates. The cells grew for 24 hours before being washed and growth arrested for 12 hours, after 
which the serum free media was replaced with treatment media. The treatment groups were:  Control 
group without supplemented D-glucose (n=6);  Normoglycaemic group supplemented with 6.1 
mmol/L D-glucose (n=6);  Hyperglycaemic group supplemented with 25 mmol/L D-glucose (n=6); 
 Osmotic control group supplemented with 6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol 
(n=6). After 48 hours of treatment each well was given a value between 0 and 5 as the survival grade, 
this was determined by the extent of visible damage in the well. Values are expressed as mean ± SEM. 
* Statistical significance from the 7.5x10
4
 seeding density (P<0.05); # Statistical significance from 
1x10
5
 seeding density (P<0.01); ‡ Statistical signficance from 1.5x10
5
 seeding density (P<0.001). 
Both intra- and inter-seeding density groups’ statistical analysis was carried out using a Kruskal-








3.1.2 Well Protein Concentration against Seeding Density 
 
Similar to the cell survival grade (Figure 3.1), increased seeding density resulted in a 
proportional increase in protein concentrations in the cell lysate after after growth arrest and 
incubation in normoglycaemic and hyperglycaemic media. 
All seeding densities significantly increased protein concentration compared to the lowest 
density of 7.5x10
4





were not significantly different from one another (P>0.05), however there was a 2.16- and 
2.56-fold increase in protein concentration compared to the 7.5x10
4
 density, respectively 
(0.38 ± 0.02 mg/mL at 7.5x10
4 
vs 0.83 ± 0.05 mg/mL at 1x10
5
 and 0.98 ± 0.04 mg/mL at 
1.5x10
5




 increased the protein 
concentration compared to 7.5x10
4





 resulted in a respective 60.0% and 55.9% increase of protein compared to 1x10
5
 and 
34.8% and 31.3% to 1.5x10
5
 (P<0.001).  
No significant difference was seen in total cell protein levels as a consequence of treatment in 






Figure 3.2 The effect of seeding density on cell lysate protein concentration in HK-2 cells 
subjected to normoglycaemic and hyperglycaemic conditions. Cells were seeded at the indicated 
densities in 24 well plates. The cells grew for 24 hours before being washed and growth arrested for 
12 hours, after which the serum free media was replaced with treatment media. The treatment groups 
are:  Control group without supplemented D-glucose (n=6);  Normoglycaemic group 
supplemented with 6.1 mmol/L D-glucose (n=6);  Hyperglycaemic group supplemented with 25 
mmol/L D-glucose (n=6);  Osmotic control group supplemented with 6.1 mmol/L D-glucose and 
18.9 mmol/L D-mannitol (n=6). Cell lysate was harvested was run through a DC
TM
 Protein Assay to 
determine the protein concentration for each well. Values are expressed as mean ± SEM. * Statistical 
significance from the 7.5x10
4
 seeding density (P<0.05); # Statistical significance from 1x10
5
 seeding 
density (P<0.001); ‡ Statistical signficance from 1.5x10
5
 seeding density (P<0.001). Statistical 








3.1.3 Correlation of Protein Concentration to Survival Grade 
 
There was a significant positive correlation between the protein concentration in the cell 
lysate and the survival grade (Figure 3.3; Spearman’s R = 0.85) determined by visible damage 
in the plate wells. 
 
Figure 3.3 The correlation of cell lysate protein concentration to cell survival grade in HK-2 cells 
subjected to normoglycaemic and hyperglycaemic conditions. As the data from the past two figures 
were taken from the same samples (n=120). The matched pairs were plotted as seen above and a 
Spearman’s Rho test was used to get R= 0.84997 with a two-tailed P value of <0.0001. This indicated 










3.1.4 Effect of different Wash Solutions on Survival Grade 
 
Changing wash solutions did not appear to increase the survival grade of HK-2 cells in the 
1x10
5
 seeding density (Figure 3.4). The only change to survival grade was a 48% increase in 
the freshly prepared PBS group compared to the original PBS, in the low 7.5x10
4
 seeded 
density (2.08 ± 0.25 in Original PBS A. vs 3.08 ± 0.31 Fresh PBS A., P<0.05). However, due 
to the fresh PBS having no effect in the 1x10
5
 density, as well as the serum-free media in 
either density, this increase may have been due to the randomness of the cell damage.  
 
Figure 3.4 The effect of different wash solutions on cell survival grade in HK-2 cells. 24 well 
culture plates were seeded at 7.5x10
4
 (A.) and 1x10
5
 (B.) cells per well with HK-2 cells. The cells 
grew for 24 hours before being washed and growth media replaced with serum free media. At this 
wash step the indicated solutions were used to wash the wells:  Original phosphate buffered saline 
(Original PBS; pH = 7.4; n=24);  Freshly prepared phosphate buffered saline (Fresh PBS; pH 7.4; 
n=12);  Growth media without serum supplementation (Serum-free Media; n=12). After being 
washed and media replaced, each well was given a value between 0 and 5 as the survival grade, this 
was determined by the extent of visible damage in the well. Values are expressed as mean ± SEM. * 
Statistical significance from Original PBS group (P<0.05). Statistical analysis was carried out using a 









3.1.5 Effect of Growth Arrest Period on Survival Grade 
 
Extending the growth arrest period from 24 to 48 hours had no significant effect on the 




 seeding density (Figure 3.5; 
P>0.05). Cells seeded at a density of 1x10
5
 showed only a 9.6% difference (P>0.05) between 
their mean survival following 24 hour (3.02 ± 0.19) vs 48 hour (3.31 ± 0.14) growth arrests. 
Different treatments with normoglycaemic and hyperglycaemic media also had no significant 
effect on cell survival in the different growth arrest times (P>0.05). 
 
Figure 3.5 Increased growth arrest period and its effect on the cell survival grade in HK-2 cells 
subjected to normoglycaemic and hyperglycaemic conditions. 24 well culture plates were seeded at 
7.5x10
4
 (A.) and 1x10
5
 (B.) cells per well with HK-2 cells. The cells grew for 24 hours before being 
washed and growth arrested for 24 and 48 hours as indicated. After growth arrest the serum free media 
was replaced with treatment media. The treatment groups are:  Control group without supplemented 
D-glucose (n=12);  Normoglycaemic group supplemented with 6.1 mmol/L D-glucose (n=12);  
Hyperglycaemic group supplemented with 25 mmol/L D-glucose (n=12);  Osmotic control group 
supplemented with 6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol (n=12). After 48 hours of 
treatment each well was given a value between 0 and 5 as the survival grade, this was determined by 
the extent of visible damage in the well. Values are expressed as mean ± SEM. Both intra- and inter-
growth arrest time groups’ statistical analysis was carried out using a Kruskal-Wallis test with a 








3.1.6 Effect of Serum Content in Growth Arrest on Survival Grade 
 
The restoration of DBS (2%) to the growth arrest media did not improve the recovery of cells 
during growth arrest (Figure 3.6).  
 
Figure 3.6 The change in survival grade after growth arrest with serum supplemented media in 
HK-2 cells. 24 well culture plates were seeded at 7.5x10
4
 (A.) and 1x10
5
 (B.) cells per well with HK-2 
cells. The cells grew for 24 hours before being washed and growth arrested for 24 hours. The control 
group was growth arrested in growth media without serum supplementation (0; n=24). The low serum 
group growth arrested for 24 hours in growth media with only 2% Donor Bovine Serum 
supplementation (2; n=24). Before and after growth arrest each well was given a value between 0 and 
5 as the survival grade, this was determined by the extent of visible damage in the well. The difference 
between values were then plotted as seen above. Values are expressed as mean ± SEM. Statistical 













3.1.7 Effect of Growth Period on Survival Grade 
 
The longer growth times (24 and 48 hours) enhanced the survival grade of all three seeding 






) (Figure 3.7). 




 seeding densities, where the 24 hour 
growth period resulted in a 4.19 fold (1.08 ± 0.08 at 12 h vs 4.54 ± 0.17 at 24 h, P<0.001; 
Figure 3.7 B.) and 3.16 fold (1.58 ± 0.12 at 12 h vs 5.00 ± 0.00 at 24 h, P<0.001; Figure 3.7 
C.) increase in survival grade, unfortunately the 2.5x10
5
 was too confluent to experiment 
further on. In the lowest seeding density (Figure 3.7 A.), growth times were extended to 48 
hours resulting in a 105% increase in survival grade from 12 hours, compared to the 69% 
increase seen at 24 hours (1.75 ± 0.17 at 12 h vs 2.96 ± 0.25 at 24 h and 3.58 ± 0.29 at 49 h, 
P<0.001). Different normoglycaemic and hyperglycaemic treatments also had no significant 
effect on cell survival in the different growth arrest times (P>0.05). 
 
Figure 3.7 Increased growth period and its effect on the cell survival grade of HK-2 cells 





 (B.) and 2.5x10
5
 (C.) The cells grew for 24 hours before being washed and growth 
arrested for 12 hours, after which the serum free media was replaced with treatment media. The 
treatment groups are:  Control group without supplemented D-glucose (n=6);  Normoglycaemic 
group supplemented with 6.1 mmol/L D-glucose (n=6);  Hyperglycaemic group supplemented with 
25 mmol/L D-glucose (n=6);  Osmotic control group supplemented with 6.1 mmol/L D-glucose and 
18.9 mmol/L D-mannitol (n=6). After 48 hours of treatment each well was given a value between 0 
and 5 as the survival grade, this was determined by the extent of visible damage in the well. Values are 
expressed as mean ± SEM. * Statistical significance from the 12 hour group (P<0.05); *** Statistical 
significance from 12 hour group (P<0.001). All intra-growth period statistical analysis was carried out 
using a Kruskal-Wallis test with a Dunn’s post-hoc, P<0.05 was considered statistically significant. 
Inter-growth period statistical analysis of the 1.5x10
5
 density was carried out using a Kruskal-Wallis 




 seeding densities used a Mann-Whitney test for 
their inter-growth period statistical analysis. 
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3.1.8 Effect of Different Well Surfaces on Survival Grade 
 
Switching cell culture plates to those of a different manufacturers did not have any significant 
effect on the survival grade of HK-2 cells (P>0.05). However, coating the original plates in 
poly-L-lysine (PLL) resulted in a 55.5% increase to survival grade (2.278±0.096 Non-Coated 
vs 3.542±0.219 PLL Coated, P<0.0001) (Figure 3.8 B.). 
Different glycaemic treatments also had no significant effect on cell survival in the different 
growth arrest times (P>0.05).
 
 
Figure 3.8 The effect of different branded cell culture late (A.) and poly-L-lysine (PLL) (B.) on 
cell survival grade in HK-2 cells subjected to normoglycaemic and hyperglycaemic conditions. 
24 well culture plates were seeded at 1x10
5
 cells per well with HK-2 cells. The cells grew for 48 hours 
before being washed and growth arrested for 24 hours, after which the serum free media was replaced 
with treatment media. The treatment groups are:  Control group without supplemented D-glucose 
(Falcon n=6; All other groups n=18);  Normoglycaemic group supplemented with 6.1 mmol/L D-
glucose (Falcon n=6; All other groups n=18);  Hyperglycaemic group supplemented with 25 
mmol/L D-glucose (Falcon n=6; All other groups n=18);  Osmotic control group supplemented 
with 6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol (Falcon n=6; All other groups n=18). After 
48 hours of treatment each well was given a value between 0 and 5 as the survival grade, this was 
determined by the extent of visible damage in the well. Values are expressed as mean ± SEM. * 
Statistical significance from Non-Coated group (P<0.0001). All intra-group statistical analysis was 
carried out using a Kruskal-Wallis test with a Dunn’s post-hoc, P<0.05 was considered statistically 





3.1.9 Changing Serum Type and the effect on Survival Grade 
 
The switch from DBS to FBS resulted in a significant increase in the survival grade in HK-2 




 cells per well (Figure 3.9; P<0.05).  
FBS increased survival grade in the 1.5x10
5
 density by 24.0% (3.56 ± 0.20 in DBS vs 4.42 ± 
0.10 in FBS, P<0.05; Figure 3.9 A.) and 11.7% in 2x10
5
 (4.27 ±0.12 in DBS vs 4.77 ±0.07 in 
FBS, P<0.05; Figure 3.9 B.). 
Different treatments with normoglycaemic and hyperglycaemic media had no significant 
effect on cell survival in the different growth arrest times (P>0.05). 
 
 
Figure 3.9 Effect of changing serum type on the cell survival grade in HK-2 cells subjected to 





 (B.) cells per well with HK-2 cells. The cells were grown in either in growth media 
supplemented with donor bovine serum (DBS; n=48) or foetal bovine serum (FBS; n=48) for 48 
hours. The wells were then washed and growth arrested for 24 hours, after which the serum free media 
was replaced with treatment media. The treatment groups are:  Control group without supplemented 
D-glucose (n=13);  Normoglycaemic group supplemented with 6.1 mmol/L D-glucose (n=13);  
Hyperglycaemic group supplemented with 25 mmol/L D-glucose (n=13);  Osmotic control group 
supplemented with 6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol (n=9). After 48 hours of 
treatment each well was given a value between 0 and 5 as the survival grade, this was determined by 
the extent of visible damage in the well. Values are expressed as mean ± SEM. * Statistical 
significance from the DBS group (P<0.05). All intra-serum groups’ statistical analysis was carried out 
using a Kruskal-Wallis test with a Dunn’s post-hoc, P<0.05 was considered statistically significant. 





3.1.10 Increasing Growth Surface Area and its effect on Survival Grade 
 
Increasing the surface area for cell growth significantly increased the survival grade of HK-2 
cells seeded at 1x10
5
 cells/mL, compared to those in 24 well plates (P<0.0001; Figure 3.10). 
Changing from 200 mm
2
 surface area in 24 well plates to 401 mm
2
 in 12 well plates resulted 
in a 37.97% increase in survival grade (3.29 ±0.26 24 Well Plate vs 4.54 ±0.13 12 Well Plate, 
P<0.0001). This effect was further enhanced at 7854 mm
2
 in the 100 mm culture dish
 
which 
caused a 51.88% improvement compared to the 24 well plate (3.29 ± 0.26 24 Well Plate vs 
5.00 ± 0.00 100 mm Dish, P<0.0001; Figure 3.10). However, the benefit of increasing growth 
area was limited beyond the 12 well plate as no statistical difference was found between the 
12 well plate and 100 mm dish (P>0.05).  
Different glycaemic treatments also had no significant effect on cell survival within the 










Figure 3.10 Increasing growth surface area and the effect on cell survival grade in HK-2 cells 
subjected to normoglycaemic and hyperglycaemic conditions. 24, and 12 well culture plates and 
100 mm petri dishes were seeded at 1x10
5
 cell/mL with HK-2 cells. The cells were grown in growth 
media supplemented foetal bovine serum (FBS) for 48 hours. The wells were then washed and growth 
arrested for 24 hours, after which the serum free media was replaced with treatment media. The 
treatment groups are:  Control group without supplemented D-glucose (n=6);  Normoglycaemic 
group supplemented with 6.1 mmol/L D-glucose (n=6);  Hyperglycaemic group supplemented with 
25 mmol/L D-glucose (n=6);  Osmotic control group supplemented with 6.1 mmol/L D-glucose and 
18.9 mmol/L D-mannitol (n=6). After 48 hours of treatment each well was given a value between 0 
and 5 as the survival grade, this was determined by the extent of visible damage in the well. Values are 
expressed as mean ± SEM. * Statistical significance from the 24 Well Plate group (P<0.0001). Both 
intra- and inter-culture vessel groups’ statistical analysis was carried out using a Kruskal-Wallis test 










3.1.11 Alternative Cell Line Wash Steps 
 
Carrying over the washing protocols used on the HK-2 cell lines resulted in no damage or 
removal of MDCK cells. As seen in the representative Figures 3.11 and 3.12, no wells in 












Figure 3.11 Result of wash protocols on the MDCK cell line in a 24 well plate seeded at 2x10
5
 
cells per well. Images taken by a Nikon Eclipse Ti-E inverted microscope system with added Nikon 
Digital Sight DS-U3 at 4x and 20x magnification. A. Centre of a well taken at 4x magnification before 
wash. B. Centre of a well taken at 20x magnification before wash. C. Top edge of a well taken at 4x 
magnification before wash. D. Top edge of a well taken at 20x magnification before wash. E. Centre 
of a well taken at 4x magnification after wash. F. Centre of a well taken at 20x magnification after 
wash. G. Top edge of a well taken at 4x magnification after wash. H. Top edge of a well taken at 20x 























Figure 3.12 Result of wash protocols on the MDCK cell line in a 12 well plate seeded at 4x10
5
 
cells per well. Images taken by a Nikon Eclipse Ti-E inverted microscope system with added Nikon 
Digital Sight DS-U3 at 4x and 20x magnification. A. Centre of a well taken at 4x magnification before 
wash. B. Centre of a well taken at 20x magnification before wash. C. Top edge of a well taken at 4x 
magnification before wash. D. Top edge of a well taken at 20x magnification before wash. E. Centre 
of a well taken at 4x magnification after wash. F. Centre of a well taken at 20x magnification after 
wash. G. Top edge of a well taken at 4x magnification after wash. H. Top edge of a well taken at 20x 



















3.2 Transforming Growth Factor-β1 Expression 
 
TGF-β1 was not found in either the conditioned or cell lysate of the HK-2 cells. No glucose 
treatment or control groups caused any change in expression (Figure 3.13), the addition of NA 
did not enhance this. The positive control obtained from homogenised kidney cortical tissue 
isolated from a rat with diabetic nephropathy (Yao et al., 2014) did however display a distinct 
25 kDa band.  
 
Figure 3.13 Transforming growth factor (TGF)-β1 expression by HK-2 cells in conditioned 
media. Developed western blot of the four glucose treatment groups: Control (0 mmol/L D-glucose), 
Normoglycaemic (6.1 mmol/L D-glucose), Hyperglycaemic (25 mmol/L D-glucose), Osmotic Control 
(6.1 mmol/L D-glucose and 18.9 mmol/L D-mannitol). Each treatment was repeated for a control, 
noradrenaline (1 nM) and ascorbic acid (0.1 nM). TGF-β1 was found at the 25 kDa band. The visible 












4 Discussion  
 
Adrenergic receptors located on proximal tubule cells were targeted in this study in order to 
optimise an in vitro model of a hypertensive diabetic patient. By focusing on adrenergic 
stimulation in the proximal tubule, the interaction between glucose and renal sympathetic 
stimulation can be specifically examined in order to better understand any interrelating 
pathways. 
Due to the role of tubulointerstitial fibrosis as an indicator of DN the profibrotic cytokine 
TGF-β1 was assessed to determine the potential interaction of noradrenaline and glucose. A 
higher production and excretion of active TGF-β1 following NA and glucose would indicate 
an increase in cellular dysfunction causing hypertrophy, epithelial-mesenchymal transition 
(EMT) and increased fibrosis, all hallmarks of DN. The results of this study indicate that 
neither noradrenaline nor glucose, alone or in combination stimulate the production or release 
of TGF-β1 from HK-2 proximal tubule cells.  
This study followed similar research publications (Hsieh et al., 2012; Gu et al., 2013) 
examining the effect of hyperglycaemic conditions in cell culture. However, our protocol 
differed with the addition of NA. There have been a limited number of studies carried out on 
the role of NA in renal injury but none have focused on a potential synergistic effect of 
sympathetic output with hyperglycaemia in the isolated cells.  
4.1 Protocol Optimisation  
 
Previous literature (Bhandari et al., 2002; Hsieh et al., 2012; Gu et al., 2013) on the HK-2 cell 
have failed to indicate any difficulty in culturing these proximal tubule cells. Consequently, 
the problems experienced with cell damage seen during washing and growth arrest protocols 
in this study were unexpected. Cell damage occurred before beginning treatment (see 
Appendix B). In order to ensure accurate and repeatable results, sections of the cell culture 
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protocol were altered in order to eliminate the monolayer disruption. The washing and media 
changing steps appeared to form the phase in which cell damage was occurring. The study 
then isolated this step for optimisation. 
The extent of the damage within the wells was recorded using a scale, based on the percentage 
area of cells left on the well surface (see Appendix B). Due to each section covering 25% of 
the total area, the data collected was ordinal, although the study aimed to compare it to a 
directly quantifiable factor. Protein content in the cell lysate was used as a quantifiable 
indicator of cell survival as cell damage would result in the loss of cells in the wash steps and 
therefore, less protein. There proved to be a strong positive correlation between the created 
survival grade scale and the directly measured protein, with a Spearman’s R value of 0.85 
confirming that the visual damage seen accurately represented a loss of cell numbers.  
While carrying out the wash protocol it was noted that damage occurred primarily after the 
media was aspirated off, suggesting that the damage may have been caused by excessive 
suction and mechanical forces on the cells.Of note, the damaged cells were localised 
predominantly around the edge of the wells. The more confluent central area of the wells 
displayed an increased survivability. It was thought that the higher confluency would increase 
cell to cell adhesion resulting in a less sensitive and more adherent cell population. 
The increased seeding densities caused significant enhancement to the survival grade of the 
cells, indicating that confluency played a role in the cells’ ability to endure the mechanical 
stress of the protocol. Unfortunately the most successful density of 2.5x10
5
 cells per well (24 
well plate) resulted in an overconfluent cell layer building up on top of the initial monolayer 
after 24 hours. To overcome this issue, the growth time was reduced to 12 hours, however this 
resulted in reduced cell survival. The lower density 1.5x10
5
 growth period was doubled to 48 
hours which resulted in a 105% increase from the 12 hour growth time. The tests on seeding 
density and growth time indicate that a higher confluency conferred greater cell survival, and 
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was achievable by either increasing seeding density or growth time. However, too high a 
seeding density resulted in overconfluence, so a minor increase in seeding density with 
increased growth times presented the best situation. By forming a single confluent monolayer 
the cells begin to form a tissue which dramatically increases their survivability (Adams et al., 
1998). The greater the degree of confluence as well as the use of a longer growth time period 
would allow for a build-up of ECM which acts to protect and secure cells (Meredith et al., 
1993). 
In order to eliminate the wash solution as a cause of the cell damage, the effect of the PBS 
itself was also tested using different batches of the buffer (see Appendix A) in the event that a 
non-physiological pH, osmolarity or ion concentration particularly Ca
2+
, may have had a 
detrimental effect on the HK-2 cells (Zager et al., 1993; Cabalgante et al.,  2012). Serum free 
media was used as a control for comparison with the two PBS solutions tested. Although the 
fresh PBS significantly improved well survival in comparison to the original PBS in the 
7.5x10
4
 seeding density, the lack of consistency in the appearance and distribution of the cell 
damage on the various plates suggest that improvement was not a direct effect of the PBS. 
This conclusion was supported by the absence of this phenomenon in the 1x10
5
 seeding 
density, or in the serum free media tests which were not significantly different to the original 
PBS results. An increased number of repeats of the fresh PBS group to increase statistical 
power and reduce deviation around the mean, may have reduced the spread of cell survival 
grades.    
Published, studies (Cabalgante et al.,  2012; Bozic et al., 2011) have been conducted using a 
24 hour growth arrest period for HK-2 cells, however the majority of publications have used a 
48 hour period. (Jones et al., 2001; Morrisey et al., 2001). It was thought that an increased 
growth arrest period would allow cells to stabilise and recover from the first media change 
and wash, therefore minimising cell damage at the treatment stage. However, there was no 
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change in cell survival between 24 and 48 hours. In order to confirm whether serum 
deprivation resulted in loss of cellular viability, resulting in the damage seen, cells were 
growth arrested in a low serum (2%) media. The change in survival grades after growth arrest 
was compared to values obtained prior to growth arrest in order to determine whether cells 
recovered or deteriorated over this 24 hour period. There was no statistical difference in 
survival between the low 2% serum and serum lacking media groups, however the mean 
change in survival was never negative. This indicates that although the addition of serum did 
not cause a significant improvement in well survival, the lack of serum did not increase 
susceptibility to damage by the second media change.    
Significant portions of the monolayers were found to be removed following washes, 
indicating reduced adherence. It is recognised that tissue culture polystyrene can vary between 
manufacturers’ products which can result in a difference in cellular responses such as 
adhesion and cytokine production (Zeiger et al., 2013). This study used 24 well plates 
produced by BIOFIL (JET BIOFIL, Guangzhou, GD, CN), these were tested against plates 
produced by Falcon (Corning Inc., Corning, NY, USA). The survival grade did not differ 
between manufacturers, indicating that the specific manufacturer’s polystyrene was not 
responsible for decreased cell adhesion.  
However, the issue of adhesion may have extended beyond the specific polystyrene material 
used. The possibility that HK-2 may have exhibited a reduction in cellular adhesion factor 
production (Sáenz-Morales et al., 2006) was counteracted by coating the surface area of the 
wells with PLL. PLL increases the positive charge of the well surface increasing the 
adherence of cells including HK-2, which have negatively charged phospholipids in the 
membrane (Bhatnagar & Kim, in press; Mazia et al., 1975) The increased attachment 
provided by PLL caused a 55.5% increase in cell survival compared to non-coated plates, 
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suggesting a lack of adhesion or too great a mechanical force which PLL was only partially 
able to compensate for.   
During the adaptation to DBS the HK-2 cells appeared to maintain their phenotype and 
growth rate. In order to confirm to our satisfaction however, that the serum used provided the 
right or sufficient amount of growth factors in order to maintain adherence, cells were grown 
back in FBS. While this optimisation test enhanced (P<0.05) the survival rating in both 
seeding densities tested, this intervention had the smallest beneficial increase of all 
optimisations. This minor benefit may be due to being provided extra beneficial proteins to 
adherence, but because the effect seen was so small, it is unlikely to contribute greatly to cell 
adherence. As FBS is isolated from a younger animal than DBS,, it is generally assumed that 
there are increased growth factors present. Cell proliferation has been linked to the age of the 
animal in which the serum had been taken (Carrel & Ebeling, 1921). Therefore the increased 
survival may have led to a minor increase in cell confluency caused by increased 
proliferation. It has been noted previously that increased confluency increases the survival 
grade, this would indicate that the FBS beneficial effect seen was not directly a result of 
increased adhesion but rather from increasing confluency and therefore survivability.  
The size of the well surface area employed in the cell growth protocols was increased for two 
reasons. The first was to increase the amount of protein harvested and the other was in order 
to spread and minimise the direct stress forces applied by washing over a larger surface area. 
Increasing the surface area proportionally decreases the pressure, as pressure is force per unit 
area. Doubling the surface area of a 24 well plate to 12 resulted in a 38% increase in survival 
grade (P<0.0001). Increasing it by 40 times to the 100 mm culture dishes only saw an added 
13.8% on top of the 12 well plates increase. This would suggest that the effect on cell survival 
was not proportional to the increase in area. However, this is the result of the 100 mm culture 
dishes being undamaged and therefore attaining the maximal survival grade.   
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As this lab have already established protocols for the MDCK cell lines, the MDCK cells were 
used as a positive control in the treatment protocol, to account for any errors in technique 
Because the MDCK wells showed no signs of damage, it reduced the likelihood that the 
damage was caused by researcher cell culture technique.  
From the various optimisation protocols tested here, two factors were found to best contribute 
to the survival of the HK-2 cells. The first being the increase in adhesion obtained by 
increasing confluency and through the use of a PLL coating, the second was the greater 
dispersal of force by increasing surface area for growth. The increased confluency as seen in 
the increased seeding densities and growth time saw the most significant effect on cell 
survival. Even the potentially indirect effect of changing serum to FBS, which can increase 
proliferation in cells thereby increasing confluency had a minor yet significant increase in 
survival. This is likely due to the heavy reliance that epithelial cells such as HK-2 have on cell 
to cell adhesion (Hills et al., 2012). This may due to their physiological role to act as a 
continuous barrier between sections in the body. In order to maintain this, epithelial cells have 
specialised molecules such as the epithelial cell adhesion molecule and E-cadherin which 
phenotypically identify them as epithelial cells and are necessary to their functioning 
(Slanchev et al., 2009; Hills et al., 2012). The increased adhesion offered by PLL coating 
directly shows the benefit of adhesion to the cell survival, however for all the increase in 
adhesion the mechanical strain of either suction or fluid movement during washing still 
caused damage to the monolayer in all but the most overconfluent of densities.  
Ultimately the most successful optimisation was the increase in surface area for cell growth. 
Although its statistical improvement was not that high compared to other optimisations, this 
was only due to reaching the maximal survival grading score and this was done without the 
aid of a PLL coating. This present study found that by increasing confluency and surface area 
we were able to overcome the cell injury produced during the wash step that resulted in cell 
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damage. This beneficial effect was most likely due to increased confluency through cell to 
cell adhesion and decreased pressure on cells by dissipating the force over a larger area. 
4.2 TGF-β1 
 
After establishing a protocol in which the HK-2 cells reproducibly displayed good viability, 
cell samples were harvested, lysed, and analysed for TGF-β1 using western blot densitometry. 
This study was unable to find any TGF-β1 in the cell lysate of conditioned media samples, 
therefore rejecting the original hypothesis. 
Because glucose has been suggested to only increase the transcription of TGF-β1 it then 
requires a secondary signal such as IL-1 or TNF-α to trigger the translation and expression of 
TGF-β1 (Phillips et al., 1995; Phillips et al., 1996; Fraser et al., 2003). The results of this study 
would indicate that NA does not fill that role as the secondary signal in the human proximal 
tubule cell line tested. This finding contradicts a current publication which indicates that HK-
2 cells express a basal level of TGF-β1 (100 µg/g of protein) in normoglycaemic levels (Hsieh 
et al., 2012; Gu et al., 2013). Therefore, even the low glucose condition of 6.1 mmol/L was 
expected to produce TGF-β1. Glucose was shown to cause a concentration-dependent increase 
in TGF-β1 production in HK-2 cells with one study recording 351.0 ± 3.2 µg/g after treatment 
with an extremely high 60 mmol/L of D-glucose (Gu et al., 2013). A study which used a 
glucose concentration which more closely resembled a clinical hyperglycaemic situation (27.5 
mmol/L D-glucose) found nearly 250 µg/g of TGF-β1, demonstrating that dramatically 
increased TGF-β1 was achievable in lower more biologically equivalent levels of glucose 
(Hsieh et al., 2012; Gu et al., 2013).  
It is surprisingly that the increase in TGF-β1 described above was not observed in the present 
study. This indicates a possible change to the cellular function of the HK-2 cells in this study. 
Chronic stress has the ability to cause a significant change in TGF-β1 signalling. This chronic 
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stress could have been caused during the culturing of the HK-2 cells. A response seen in 
fibroblasts to chronic injury is the eventual down regulation of the TGF-β1 signalling pathway 
(Kim et al., 2003). While chronic injury is synonymous with increased TGF-β1 this study 
indicates over time the cell develops tolerance to its signalling, by down regulating TGF-β II 
receptors and decreased activation of Smad 2 and 3. Because a major stimulatory pathway for 
the production of TGF-β1 is through TGF-β1 signalling (Wolfman et al., 2003; Xu et al., 
2012; Kato, 2013), this would indicate decreasing TGF-β1 signalling will cause decreased 
TGF-β1 production. This may explain why TGF-β1 levels were not detectable in this study if it 
is being repressed by its own inability to upregulate itself.  
This chronic stress may also have attributed the damage seen in the optimisation phase of this 
study (Sáenz-Morales et al., 2006). Chronic stress will cause a rise in TGF-β1 cells and within 
PTCs such as the HK-2 they will begin to go through EMT (Yu & Stamenkovic, 2000; Kim et 
al., 2007). One consequence of this is the loss of epithelial phenotypes such as E-cadherin and 
other adhesion molecules (Papageorgis et al., 2010; Hills et al., 2012). This would result in 
the decreased adhesion, as seen in this study. 
However, it must be noted that the procedures employed in lyophilising the conditioned 
media to concentrating the cellular protein extract may have resulted in a high salt 
concentration in the lyophilised product. After resuspending the lyophilised media in 300 µL 
of deionised water, the sodium chloride had a molarity of 4.020 M, calculated on its 
concentration in the media of 6995.5 mg/L. This high salt concentration can cause 
complications in western blotting. The high salt content may create a less soluble sample 
which will impede the flow through the electrophoresis gel, as well as the high ion content 
interfering with the binding of proteins to sodium dodecyl sulphate (See et al., 1986). This has 
the potential to cause irregularities in the separation of proteins as well as reducing their 
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signal. This may have resulted in the samples failing to run properly and therefore give the 
negative western blot results seen. 
Other limitations are the limited amount of times this experiment was successfully run to 
completion, therefore allowing little time to trouble shoot the lyophilised product for western 
blot compatibility in order to assess if the high salt content was responsible for the lack of 
TGF-β1 detected.  
4.3 Conclusions 
 
DN is an increasing issue within the constantly expanding diabetic community. DN is known 
to be accelerated by hypertension, a highly prevalent condition in diabetes due to linked 
lifestyle and genetic factors. Renal denervation has had some success in reducing the extent of 
renal injury in DN. However, a targeted pharmacological method of attenuating the effects of 
hypertension on the kidneys would be preferential, compared to the surgery requiring 
cauterising or severing of the renal nerves. In order to better understand the interaction 
between sympathetic stimulation and hyperglycaemia, their potential interactions need to be 
broken down and examined individually.  
This study aimed to try and better understand the roles of the adrenergic receptors in the 
proximal tubule, as these cells are considered critical to the development on interstitial 
fibrosis in DN. This study found no trace of the profibrotic cytokine TGF-β1 indicating a lack 
of synergistic upregulation. However, this was in direct contrast to other studies working with 
the same cells which found a basal level of TGF-β1 that this study did not, as well as the 
stimulated excretion by glucose. Because of the total lack of TGF-β1 it is possible that the 
cells had suffered chronic stress resulting in the inhibition of TGF-β1 signalling preventing the 
stimulation of TGF-β1 production through the self-stimulatory pathway of TGF-β and Smad 
signalling. This would also explain the increased cell damage seen in the optimisation period 
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of this study, as the chronic injury would have resulted in EMT causing a loss of epithelial 
phenotypes such as E-cadherin. This could have caused the increased frailty experience by 
these cells during washing steps due to mechanical and or suction stress. 
4.4 Future Directions for Study 
 
An interesting direction would be to analyse the cell lysate for levels of E-cadherin to further 
confirm or deny the reasoning for cell damage and lack of TGF-β1. It was unfortunate that a 
lack of time prevented more completed experiments as well as increasing NA concentrations 
to see if they elicited a response.  
The vast majority of research that has looked into the upregulation of TGF-β1 by glucose and 
NA used enzyme-linked immunosorbent assay (ELISA) to determine the concentration in 
conditioned media (Hsieh et al., 2012; Gu et al., 2013; Kim & Padanilam, 2013). It would be 
worth analysing the conditioned media through this current protocol to see if there would 
difference in detection between an ELISA analysis or a western blot.  
A co-culture of PTCs and fibroblasts would be more indicative of the conditions in DN, as 
fibroblasts are the main contributors to increased fibrosis a co-culture would allow for the 
interactions between cells to be studied. This is important due to PTCs supposed role in 










5.1 Appendix A – Solutions 
 
Blocking Solution 
The blocking buffer was made up to 5% skim milk powder and 0.1% BSA in TTBS. 
Cell Lysis Buffer - pH 8 
The lysis buffer was made up to the following concentrations: Tris-HCl 50 mM, NaCl 150 
mM, 1% SDS and 1% Triton X100, in deionised purified water.  
Cryogenic Freezing Media 
The media was a mixture of 90% growth media and 10% DMSO. 
10x Phosphate Buffered Saline (PBS) – 1 L 
80 g of NaCl, 2 g KCl, 14.4 g Na2HPO4 and 2.4 g KH2PO4 were added to 800 mL of 
deionised purified water. It was pH balanced using the Sente Jenway 3045 Ion Analyser and 
brought up to 1 L. 
10x Tris-Buffered Saline (TBS) – 1 L 
80 g of NaCl, 2 g KCl and 30g of Trisbase were added to 800 mL of deionised purified water. 
It was pH balanced using the Sente Jenway 3045 Ion Analyser and brought up to 1 L. 
Tween Tris-Buffered Saline (TTBS) 




5.2 HK-2 cell damage after directly after wash step 
 
Representative damage occurring in HK-2 wells at seeding density 7.5x10
4
 cells per well in 
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